Go to the Table of Contents

110405
Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 16,599 16,292 508 561 167 288
GENDER            
Male 11,572 11,161 389 439 112 245
Female 5,027 5,132 119 121 55 43
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15,299 14,938 401 487 122 234
White 14,189 13,531 349 449 101 225
Black or African American 577 687 * 25 * 3
American Indian or Alaska Native 69b 173 2 1 0 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 207 259 25 1 11 *
Two or More Races 246 269 24 12 9 5
Hispanic or Latino 1,300 1,354 107 73 46 54
EDUCATION            
< High School 1,814 1,886 54 44 8 10
High School Graduate 3,949 3,628 75 58 44 33
Some College 4,620 4,504 183 279 43 132
College Graduate 6,216 6,274 196 179 73 112
CURRENT EMPLOYMENT            
Full-Time 10,973 10,646 273 383 120 217
Part-Time 1,995 2,119 102 80 6 38
Unemployed 1,226 931 60 29 17 29
Other1 2,405 2,595 74 68 23 4
110405
Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 8.6 8.3 0.3 0.3 0.1 0.1
GENDER            
Male 12.5 11.9 0.4 0.5 0.1 0.3
Female 5.0 5.1 0.1 0.1 0.1 0.0
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.1 8.8 0.2 0.3 0.1 0.1
White 10.5 10.0 0.3 0.3 0.1 0.2
Black or African American 2.7 3.2 * 0.1 * 0.0
American Indian or Alaska Native 8.0b 19.4 0.3 0.1 0.1 *
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 2.4 2.9 0.3 0.0 0.1 *
Two or More Races 12.3 12.8 1.2 0.6 0.5 0.3
Hispanic or Latino 5.2 5.4 0.4 0.3 0.2 0.2
EDUCATION            
< High School 6.3 6.5 0.2 0.2 0.0 0.0
High School Graduate 6.8 6.3 0.1 0.1 0.1 0.1
Some College 9.9 9.5 0.4 0.6 0.1 0.3
College Graduate 10.3 10.3 0.3 0.3 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 10.7 10.5 0.3 0.4 0.1 0.2
Part-Time 8.9 9.0 0.5 0.3 0.0 0.2
Unemployed 12.0 9.1 0.6 0.3 0.2 0.3
Other1 4.1 4.4 0.1 0.1 0.0 0.0
110405
Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 20,180 19,655 1,134 1,149 315 423
GENDER            
Male 13,759 13,204 793 808 216 330
Female 6,421 6,451 341 341 99 93
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 18,295 17,787 892 984 232 343
White 16,887 16,022 789 880 198 301
Black or African American 726 877 19 55 9 27
American Indian or Alaska Native 112a 200 7 12 0 2
Native Hawaiian or Other Pacific Islander 20 28 3 1 1 1
Asian 254 332 40 15 13 5
Two or More Races 296 328 33 21 9 7
Hispanic or Latino 1,886 1,869 242 165 84 80
EDUCATION            
< High School 2,526 2,485 192 186 43 40
High School Graduate 5,215 4,808 288 271 93 88
Some College 5,759 5,635 407 461 100 168
College Graduate 6,681 6,727 248 231 79 126
CURRENT EMPLOYMENT            
Full-Time 12,448 11,951 446 597 159 271
Part-Time 2,916 3,069 269 259 62 79
Unemployed 1,790a 1,438 203a 110 47 47
Other1 3,026 3,198 217 184 47 26
110405
Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 8.9 8.6 0.5 0.5 0.1 0.2
GENDER            
Male 12.5 11.9 0.7 0.7 0.2 0.3
Female 5.5 5.5 0.3 0.3 0.1 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.3 9.0 0.5 0.5 0.1 0.2
White 10.9 10.3 0.5 0.6 0.1 0.2
Black or African American 2.8 3.3 0.1 0.2 0.0 0.1
American Indian or Alaska Native 10.3a 18.6 0.7 1.1 0.0 0.2
Native Hawaiian or Other Pacific Islander 2.7 4.3 0.4 0.1 0.1 0.1
Asian 2.5 3.2 0.4 0.1 0.1 0.0
Two or More Races 12.2 12.4 1.4 0.8 0.4 0.3
Hispanic or Latino 6.1 5.9 0.8 0.5 0.3 0.3
EDUCATION            
< High School 7.3 7.1 0.6 0.5 0.1 0.1
High School Graduate 7.4 6.9 0.4 0.4 0.1 0.1
Some College 10.0 9.5 0.7 0.8 0.2 0.3
College Graduate 10.3 10.3 0.4 0.4 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 10.8 10.5 0.4 0.5 0.1 0.2
Part-Time 9.2 9.3 0.8 0.8 0.2 0.2
Unemployed 12.1a 9.7 1.4a 0.7 0.3 0.3
Other1 4.6 4.8 0.3 0.3 0.1 0.0
110517
Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 51,771 51,641 16,006 16,031 6,953 6,967
AGE            
12-17 2,796a 2,583 1,885 1,812 772 725
18-25 9,819 9,780 5,027 4,862 2,119 2,003
26 or Older 39,156 39,277 9,093 9,357 4,062 4,239
GENDER            
Male 26,979 27,807 8,445 8,609 3,840 3,686
Female 24,792 23,834 7,561 7,422 3,114 3,281
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 46,010 45,931 13,823 13,850 6,107 6,030
White 40,401 39,573 11,880 11,662 5,119 5,145
Black or African American 3,519 3,995 1,216 1,335 599 602
American Indian or Alaska Native 399 327 130 129 76 55
Native Hawaiian or Other Pacific Islander * 70 * 29 * 18
Asian 816 1,084 302 440 155 111
Two or More Races 759 882 226 256 100 99
Hispanic or Latino 5,760 5,710 2,183 2,180 847 937
110517
Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 20.6 20.4 6.4 6.3 2.8 2.7
AGE            
12-17 11.4a 10.6 7.7 7.4 3.1 3.0
18-25 29.2 28.7 15.0 14.3 6.3 5.9
26 or Older 20.2 20.1 4.7 4.8 2.1 2.2
GENDER            
Male 22.1 22.5 6.9 7.0 3.1 3.0
Female 19.1 18.3 5.8 5.7 2.4 2.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.3 21.2 6.4 6.4 2.8 2.8
White 23.8 23.3 7.0 6.9 3.0 3.0
Black or African American 11.7 13.2 4.0 4.4 2.0 2.0
American Indian or Alaska Native 32.6 27.2 10.6 10.7 6.2 4.6
Native Hawaiian or Other Pacific Islander * 9.6 * 4.0 * 2.4
Asian 7.4 9.5 2.7 3.8 1.4 1.0
Two or More Races 25.7 27.8 7.6 8.1 3.4 3.1
Hispanic or Latino 16.0 15.5 6.1 5.9 2.4 2.5
110517
Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 2,796a 2,583 1,885 1,812 772 725
GENDER            
Male 1,345a 1,200 876 811 352 288
Female 1,450 1,383 1,009 1,001 420 437
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 2,218b 2,013 1,515 1,414 615 560
White 1,639 1,502 1,158 1,095 446 411
Black or African American 405 343 260 208 129 94
American Indian or Alaska Native 22 22 14 15 4 4
Native Hawaiian or Other Pacific Islander * 7 * * * 1
Asian 79 58 45 35 19 19
Two or More Races 59 81 32a 59 14 31
Hispanic or Latino 578 571 370 397 157 165
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 779a 670 543 479 209 164
Female, White, Not Hispanic 860 831 615 616 237 246
Male, Black, Not Hispanic 205 149 126a 82 56 37
Female, Black, Not Hispanic 201 194 133 126 73 57
Male, Hispanic 282 305 174 204 74 70
Female, Hispanic 296 266 196 193 83 95
110517
Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 11.4a 10.6 7.7 7.4 3.1 3.0
GENDER            
Male 10.7a 9.6 7.0 6.5 2.8 2.3
Female 12.0 11.6 8.4 8.4 3.5 3.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 11.2a 10.4 7.6 7.3 3.1 2.9
White 11.4 10.7 8.1 7.8 3.1 2.9
Black or African American 10.9 9.6 7.0 5.8 3.5 2.6
American Indian or Alaska Native 16.8 16.9 11.1 11.5 3.0 3.4
Native Hawaiian or Other Pacific Islander * 9.7 * * * 1.6
Asian 8.0 5.5 4.5 3.3 1.9 1.8
Two or More Races 11.2 15.4 6.1a 11.2 2.6 5.8
Hispanic or Latino 12.0 11.6 7.7 8.1 3.3 3.4
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 10.6a 9.3 7.4 6.6 2.8 2.3
Female, White, Not Hispanic 12.3 12.1 8.8 9.0 3.4 3.6
Male, Black, Not Hispanic 11.0 8.3 6.8a 4.6 3.0 2.1
Female, Black, Not Hispanic 10.9 10.9 7.2 7.1 3.9 3.2
Male, Hispanic 11.4 12.0 7.1 8.0 3.0 2.8
Female, Hispanic 12.6 11.2 8.4 8.2 3.5 4.0
110517
Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9,819 9,780 5,027 4,862 2,119 2,003
GENDER            
Male 5,205 5,247 2,787 2,676 1,209 1,100
Female 4,614 4,533 2,240 2,186 910 903
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8,402 8,323 4,331 4,220 1,807 1,754
White 7,237 7,130 3,752 3,652 1,567 1,515
Black or African American 736 731 361 351 148 163
American Indian or Alaska Native 85 59 47 28 30 19
Native Hawaiian or Other Pacific Islander * * * 11 * *
Asian 170 196 93 92 33 26
Two or More Races 146 181 62 86 23 25
Hispanic or Latino 1,417 1,457 696 642 312 249
EDUCATION            
< High School 1,924a 1,699 994 866 480 416
High School Graduate 3,424 3,228 1,776 1,605 738 711
Some College 3,176 3,421 1,660 1,720 675 682
College Graduate 1,295 1,432 597 671 226 194
CURRENT EMPLOYMENT            
Full-Time 3,774 3,783 1,793 1,768 764 771
Part-Time 2,598 2,744 1,409 1,421 611a 494
Unemployed 1,486 1,343 812a 685 345 350
Other1 1,960 1,911 1,013 988 400 389
110517
Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 29.2 28.7 15.0 14.3 6.3 5.9
GENDER            
Male 30.8 30.4 16.5 15.5 7.2 6.4
Female 27.6 27.0 13.4 13.0 5.5 5.4
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 30.6 30.3 15.8 15.3 6.6 6.4
White 35.5 35.1 18.4 18.0 7.7 7.4
Black or African American 15.3 15.0 7.5 7.2 3.1 3.3
American Indian or Alaska Native 36.7 32.2 20.3 15.4 12.9 10.5
Native Hawaiian or Other Pacific Islander * * * 7.8 * *
Asian 11.2 13.6 6.1 6.4 2.1 1.8
Two or More Races 34.1 33.2 14.5 15.8 5.4 4.6
Hispanic or Latino 23.1 22.2 11.4 9.8 5.1 3.8
EDUCATION            
< High School 31.6a 28.8 16.3 14.7 7.9 7.0
High School Graduate 29.2 27.4 15.1a 13.6 6.3 6.0
Some College 28.7 29.4 15.0 14.8 6.1 5.9
College Graduate 27.5 30.1 12.7 14.1 4.8 4.1
CURRENT EMPLOYMENT            
Full-Time 30.5 30.5 14.5 14.3 6.2 6.2
Part-Time 27.7 28.7 15.0 14.9 6.5a 5.2
Unemployed 32.6 29.6 17.8a 15.1 7.6 7.7
Other1 26.9 25.2 13.9 13.0 5.5 5.1
110517
Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 39,156 39,277 9,093 9,357 4,062 4,239
GENDER            
Male 20,429 21,360 4,782 5,123 2,278 2,299
Female 18,727 17,917 4,311 4,234 1,784 1,941
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 35,390 35,595 7,977 8,216 3,685 3,716
White 31,526 30,941 6,969 6,915 3,106 3,220
Black or African American 2,378 2,920 596 775 323 345
American Indian or Alaska Native * 246 * 85 * 32
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 567 830 164 314 103 66
Two or More Races 554 620 131 111 63 43
Hispanic or Latino 3,766 3,682 1,116 1,141 377 523
EDUCATION            
< High School 4,947 4,825 1,538 1,420 827 732
High School Graduate 11,153 10,656 2,619 2,495 1,190 1,142
Some College 10,948 11,619 2,350 2,716 1,103 1,185
College Graduate 12,108 12,177 2,587 2,725 942 1,181
CURRENT EMPLOYMENT            
Full-Time 23,654 23,167 5,114 5,413 2,047 2,411
Part-Time 4,896 5,239 1,204 1,107 487 481
Unemployed 3,025 2,831 832 880 421 416
Other1 7,580 8,040 1,944 1,957 1,107 931
110517
Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 20.2 20.1 4.7 4.8 2.1 2.2
GENDER            
Male 22.0 22.8 5.2 5.5 2.5 2.5
Female 18.6 17.7 4.3 4.2 1.8 1.9
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.0 20.9 4.7 4.8 2.2 2.2
White 23.3 22.8 5.2 5.1 2.3 2.4
Black or African American 11.0 13.4 2.8 3.6 1.5 1.6
American Indian or Alaska Native * 27.7 * 9.6 * 3.6
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 6.6 9.3 1.9 3.5 1.2 0.7
Two or More Races 27.7 29.4 6.6 5.3 3.2 2.0
Hispanic or Latino 15.1 14.6 4.5 4.5 1.5 2.1
EDUCATION            
< High School 17.3 16.6 5.4 4.9 2.9 2.5
High School Graduate 19.1 18.4 4.5 4.3 2.0 2.0
Some College 23.5 24.5 5.0 5.7 2.4 2.5
College Graduate 20.2 20.0 4.3 4.5 1.6 1.9
CURRENT EMPLOYMENT            
Full-Time 23.1 22.8 5.0 5.3 2.0 2.4
Part-Time 21.8 22.2 5.4 4.7 2.2 2.0
Unemployed 29.7 27.6 8.2 8.6 4.1 4.1
Other1 12.9 13.5 3.3 3.3 1.9 1.6
110517
Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 48,975 49,058 14,120 14,219 6,182 6,242
GENDER            
Male 25,634 26,607 7,569 7,799 3,488 3,399
Female 23,341 22,451 6,552 6,420 2,694 2,844
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 43,793 43,918 12,308 12,436 5,492 5,470
White 38,763 38,071 10,722 10,567 4,673 4,735
Black or African American 3,114 3,651 956 1,127 471 508
American Indian or Alaska Native 377 305 116 114 72 51
Native Hawaiian or Other Pacific Islander * 64 * 27 * *
Asian 737 1,026 257 405 136 92
Two or More Races 700 801 194 197 87 68
Hispanic or Latino 5,182 5,139 1,812 1,783 690 772
EDUCATION            
< High School 6,871 6,524 2,532 2,286 1,307 1,148
High School Graduate 14,577 13,884 4,395 4,100 1,928 1,854
Some College 14,124 15,040 4,009 4,436 1,779 1,866
College Graduate 13,403 13,609 3,184 3,396 1,168 1,375
CURRENT EMPLOYMENT            
Full-Time 27,428 26,950 6,907 7,181 2,811 3,182
Part-Time 7,494 7,983 2,612 2,528 1,098 974
Unemployed 4,512 4,174 1,644 1,564 766 766
Other1 9,540 9,951 2,957 2,945 1,507 1,321
110517
Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 21.6 21.4 6.2 6.2 2.7 2.7
GENDER            
Male 23.4 24.0 6.9 7.0 3.2 3.1
Female 19.9 19.0 5.6 5.4 2.3 2.4
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 22.3 22.2 6.3 6.3 2.8 2.8
White 24.9 24.4 6.9 6.8 3.0 3.0
Black or African American 11.8 13.7 3.6 4.2 1.8 1.9
American Indian or Alaska Native 34.4 28.4 10.6 10.6 6.6 4.7
Native Hawaiian or Other Pacific Islander * 9.6 * 4.0 * *
Asian 7.3 9.9 2.6 3.9 1.4 0.9
Two or More Races 28.8 30.2 8.0 7.4 3.6 2.6
Hispanic or Latino 16.6 16.1 5.8 5.6 2.2 2.4
EDUCATION            
< High School 19.8 18.6 7.3 6.5 3.8 3.3
High School Graduate 20.8 20.0 6.3 5.9 2.8 2.7
Some College 24.5 25.5 6.9 7.5 3.1 3.2
College Graduate 20.7 20.8 4.9 5.2 1.8 2.1
CURRENT EMPLOYMENT            
Full-Time 23.9 23.6 6.0 6.3 2.4 2.8
Part-Time 23.6 24.1 8.2 7.6 3.5 2.9
Unemployed 30.6 28.2 11.1 10.6 5.2 5.2
Other1 14.5 14.8 4.5 4.4 2.3 2.0
110405
Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 35,046 34,776 12,405 12,213 5,257 5,100
AGE            
12-17 2,378 2,238 1,616 1,522 653 611
18-25 8,156 8,098 4,000 3,769 1,600 1,519
26 or Older 24,513 24,439 6,789 6,923 3,004 2,971
GENDER            
Male 19,365 19,412 6,865 6,941 2,976 2,882
Female 15,682 15,363 5,539 5,272 2,281 2,218
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 31,047 30,618 10,717 10,437 4,621 4,359
White 26,780 25,856 9,037 8,622 3,778 3,659
Black or African American 2,714a 3,212 1,064 1,094 483 478
American Indian or Alaska Native 327 233 125 106 74 48
Native Hawaiian or Other Pacific Islander * 46 * 25 * 18
Asian 596 721 250 369 148 79
Two or More Races 538 550 178 220 83 77
Hispanic or Latino 4,000 4,158 1,688 1,776 636 741
110405
Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 13.9 13.7 4.9 4.8 2.1 2.0
AGE            
12-17 9.7 9.2 6.6 6.2 2.7 2.5
18-25 24.3 23.8 11.9a 11.1 4.8 4.5
26 or Older 12.7 12.5 3.5 3.5 1.6 1.5
GENDER            
Male 15.8 15.7 5.6 5.6 2.4 2.3
Female 12.1 11.8 4.3 4.0 1.8 1.7
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.4 14.1 5.0 4.8 2.1 2.0
White 15.8 15.2 5.3 5.1 2.2 2.2
Black or African American 9.0a 10.6 3.5 3.6 1.6 1.6
American Indian or Alaska Native 26.7 19.3 10.2 8.8 6.0 4.0
Native Hawaiian or Other Pacific Islander * 6.4 * 3.4 * 2.4
Asian 5.4 6.3 2.3 3.2 1.3 0.7
Two or More Races 18.2 17.3 6.0 6.9 2.8 2.4
Hispanic or Latino 11.1 11.3 4.7 4.8 1.8 2.0
110405
Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 2,378 2,238 1,616 1,522 653 611
GENDER            
Male 1,169 1,055 751 693 300 252
Female 1,208 1,183 866 829 353 359
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,874 1,741 1,283 1,201 513 471
White 1,374 1,294 967 926 368 347
Black or African American 351 298 227 179 107 81
American Indian or Alaska Native 19 19 12 14 3 4
Native Hawaiian or Other Pacific Islander * 6 * * * 1
Asian 68 52 41 29 18 17
Two or More Races 53 71 29 51 13 21
Hispanic or Latino 503 498 334 321 140 140
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 669 583 453 410 177 141
Female, White, Not Hispanic 705 711 514 516 191 206
Male, Black, Not Hispanic 179 131 110a 69 46 30
Female, Black, Not Hispanic 173 167 117 110 61 51
Male, Hispanic 251 271 157 173 66 65
Female, Hispanic 252 227 177 148 74 74
110405
Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9.7 9.2 6.6 6.2 2.7 2.5
GENDER            
Male 9.3 8.5 6.0 5.6 2.4 2.0
Female 10.0 10.0 7.2 7.0 2.9 3.0
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 9.5 9.0 6.5 6.2 2.6 2.4
White 9.6 9.2 6.7 6.6 2.6 2.5
Black or African American 9.5 8.3 6.1 5.0 2.9 2.3
American Indian or Alaska Native 14.3 14.4 9.5 10.6 2.7 3.1
Native Hawaiian or Other Pacific Islander * 9.4 * * * 1.4
Asian 6.9 4.9 4.1 2.8 1.9 1.6
Two or More Races 10.1 13.6 5.6a 9.6 2.4 4.0
Hispanic or Latino 10.5 10.1 6.9 6.5 2.9 2.8
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 9.1 8.1 6.2 5.7 2.4 2.0
Female, White, Not Hispanic 10.1 10.4 7.3 7.5 2.7 3.0
Male, Black, Not Hispanic 9.6 7.3 5.9a 3.9 2.5 1.7
Female, Black, Not Hispanic 9.4 9.4 6.3 6.1 3.3 2.9
Male, Hispanic 10.2 10.7 6.4 6.8 2.7 2.6
Female, Hispanic 10.7 9.6 7.5 6.3 3.2 3.1
110405
Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 8,156 8,098 4,000 3,769 1,600 1,519
GENDER            
Male 4,444 4,517 2,275 2,168 928 887
Female 3,712 3,582 1,726 1,600 672 632
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 7,052 6,896 3,457 3,279 1,369 1,313
White 6,071 5,899 2,981 2,810 1,177 1,118
Black or African American 647 629 305 290 115 133
American Indian or Alaska Native 77a 44 45 26 28 17
Native Hawaiian or Other Pacific Islander * * * 11 * *
Asian 123 145 69 68 28 17
Two or More Races 117 155 47 74 16 22
Hispanic or Latino 1,104 1,203 543 490 231 206
EDUCATION            
< High School 1,623a 1,446 820 726 385 331
High School Graduate 2,924 2,782 1,469 1,301 603 585
Some College 2,632 2,779 1,302 1,298 485 488
College Graduate 977 1,091 409 444 127 114
CURRENT EMPLOYMENT            
Full-Time 3,140 3,196 1,445 1,396 595 592
Part-Time 2,186 2,205 1,117 1,039 439a 347
Unemployed 1,251 1,165 655 563 274 283
Other1 1,579 1,533 783 770 293 297
110405
Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 24.3 23.8 11.9a 11.1 4.8 4.5
GENDER            
Male 26.3 26.1 13.5 12.5 5.5 5.1
Female 22.2 21.3 10.3 9.5 4.0 3.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 25.7 25.1 12.6 11.9 5.0 4.8
White 29.8 29.0 14.6 13.8 5.8 5.5
Black or African American 13.5 12.9 6.3 6.0 2.4 2.7
American Indian or Alaska Native 33.6 24.4 19.5 14.1 12.3 9.5
Native Hawaiian or Other Pacific Islander * * * 7.8 * *
Asian 8.1 10.1 4.6 4.7 1.9 1.2
Two or More Races 27.3 28.5 11.0 13.5 3.7 4.1
Hispanic or Latino 18.0 18.3 8.9 7.5 3.8 3.1
EDUCATION            
< High School 26.7 24.5 13.5 12.3 6.3 5.6
High School Graduate 24.9 23.6 12.5a 11.1 5.1 5.0
Some College 23.8 23.9 11.8 11.2 4.4 4.2
College Graduate 20.7 22.9 8.7 9.3 2.7 2.4
CURRENT EMPLOYMENT            
Full-Time 25.4 25.8 11.7 11.3 4.8 4.8
Part-Time 23.3 23.1 11.9 10.9 4.7a 3.6
Unemployed 27.5 25.6 14.4 12.4 6.0 6.2
Other1 21.7 20.2 10.8 10.2 4.0 3.9
110405
Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 24,513 24,439 6,789 6,923 3,004 2,971
GENDER            
Male 13,751 13,840 3,840 4,079 1,748 1,743
Female 10,762 10,599 2,948 2,843 1,256 1,227
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 22,120 21,981 5,977 5,957 2,739 2,575
White 19,335 18,663 5,089 4,886 2,233 2,195
Black or African American 1,716a 2,285 532 626 260 264
American Indian or Alaska Native * 169 * 66 * 27
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 405 524 140 272 102 46
Two or More Races 368 323 102 96 55 34
Hispanic or Latino 2,393 2,458 811 966 265 395
EDUCATION            
< High School 3,363 3,255 1,218 1,136 652 579
High School Graduate 7,322 6,701 2,139 1,836 994 852
Some College 6,901 7,364 1,714 2,142 751 855
College Graduate 6,927 7,119 1,717 1,809 607 685
CURRENT EMPLOYMENT            
Full-Time 15,023 14,850 3,739 4,019 1,481 1,675
Part-Time 3,013 3,024 836 814 330 359
Unemployed 2,070 2,026 683 669 309 298
Other1 4,406 4,539 1,530 1,420 884 639
110405
Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 12.7 12.5 3.5 3.5 1.6 1.5
GENDER            
Male 14.8 14.8 4.1 4.4 1.9 1.9
Female 10.7 10.4 2.9 2.8 1.2 1.2
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 13.1 12.9 3.5 3.5 1.6 1.5
White 14.3 13.8 3.8 3.6 1.7 1.6
Black or African American 8.0a 10.5 2.5 2.9 1.2 1.2
American Indian or Alaska Native * 19.0 * 7.5 * 3.0
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 4.8 5.8 1.6 3.0 1.2 0.5
Two or More Races 18.4 15.3 5.1 4.6 2.7 1.6
Hispanic or Latino 9.6 9.7 3.2 3.8 1.1 1.6
EDUCATION            
< High School 11.8 11.2 4.3 3.9 2.3 2.0
High School Graduate 12.6 11.6 3.7 3.2 1.7 1.5
Some College 14.8 15.5 3.7 4.5 1.6 1.8
College Graduate 11.5 11.7 2.9 3.0 1.0 1.1
CURRENT EMPLOYMENT            
Full-Time 14.7 14.6 3.7 4.0 1.4 1.6
Part-Time 13.4 12.8 3.7 3.5 1.5 1.5
Unemployed 20.3 19.7 6.7 6.5 3.0 2.9
Other1 7.5 7.6 2.6 2.4 1.5 1.1
110405
Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 32,669 32,537 10,789 10,691 4,604 4,490
GENDER            
Male 18,195 18,357 6,115 6,248 2,676 2,630
Female 14,473 14,180 4,674 4,443 1,928 1,859
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 29,172 28,877 9,434 9,236 4,108 3,888
White 25,406 24,562 8,070 7,696 3,409 3,312
Black or African American 2,363a 2,914 837 916 376 396
American Indian or Alaska Native 308 214 112 92 70 44
Native Hawaiian or Other Pacific Islander * 40 * 22 * *
Asian 528 669 210 340 130 63
Two or More Races 485 479 149 170 71 56
Hispanic or Latino 3,497 3,660 1,355 1,455 496 601
EDUCATION            
< High School 4,987 4,701 2,039 1,862 1,037 911
High School Graduate 10,245 9,483 3,608a 3,137 1,597 1,437
Some College 9,533 10,143 3,016 3,440 1,236 1,343
College Graduate 7,903 8,210 2,126 2,252 734 799
CURRENT EMPLOYMENT            
Full-Time 18,163 18,045 5,184 5,415 2,075 2,267
Part-Time 5,199 5,230 1,953 1,853 769 705
Unemployed 3,322 3,190 1,338 1,232 583 581
Other1 5,986 6,072 2,313 2,191 1,176 935
110405
Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2009 and 2010
Demographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes retired persons, disabled persons, homemakers, students, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.4 14.2 4.7 4.7 2.0 2.0
GENDER            
Male 16.6 16.5 5.6 5.6 2.4 2.4
Female 12.3 12.0 4.0 3.8 1.6 1.6
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.9 14.6 4.8 4.7 2.1 2.0
White 16.3 15.7 5.2 4.9 2.2 2.1
Black or African American 9.0a 10.9 3.2 3.4 1.4 1.5
American Indian or Alaska Native 28.2 19.9 10.3 8.6 6.4 4.1
Native Hawaiian or Other Pacific Islander * 6.0 * 3.4 * *
Asian 5.3 6.4 2.1 3.3 1.3 0.6
Two or More Races 20.0 18.0 6.1 6.4 2.9 2.1
Hispanic or Latino 11.2 11.5 4.4 4.6 1.6 1.9
EDUCATION            
< High School 14.4 13.4 5.9 5.3 3.0 2.6
High School Graduate 14.6 13.6 5.1a 4.5 2.3 2.1
Some College 16.5 17.2 5.2 5.8 2.1 2.3
College Graduate 12.2 12.5 3.3 3.4 1.1 1.2
CURRENT EMPLOYMENT            
Full-Time 15.8 15.8 4.5 4.7 1.8 2.0
Part-Time 16.4 15.8 6.1 5.6 2.4 2.1
Unemployed 22.5 21.5 9.1 8.3 4.0 3.9
Other1 9.1 9.0 3.5 3.3 1.8 1.4
120404
Table 1.59A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 119,259 119,933 38,123 38,908 21,930 22,648
GEOGRAPHIC DIVISION            
Northeast 22,413 22,990 7,480 7,360 4,375 4,421
New England 6,625 6,615 2,370 2,210 1,452 1,413
Middle Atlantic 15,789 16,375 5,110 5,150 2,923 3,007
Midwest 26,718 26,248 7,666 7,873 4,353 4,533
East North Central 18,818 18,750 5,563 5,894 3,191 3,466
West North Central 7,900 7,497 2,104 1,978 1,162 1,068
South 41,016 41,393 12,731 12,637 7,209 7,228
South Atlantic 22,827 22,273 6,978 6,957 4,006 4,038
East South Central 6,445 6,726 1,815 1,907 1,041 1,076
West South Central 11,743 12,395 3,938 3,773 2,162 2,114
West 29,112 29,302 10,246 11,038 5,993 6,466
Mountain 8,921 9,208 2,971a 3,469 1,696a 2,037
Pacific 20,191 20,094 7,275 7,569 4,297 4,429
COUNTY TYPE            
Large Metro 64,271 66,195 21,025 21,977 12,133 12,801
Small Metro 37,003 36,587 11,839 11,858 6,783 6,827
250K - 1 Mil. Pop. 24,841 24,847 7,876 8,040 4,491 4,613
< 250K Pop. 12,162 11,739 3,963 3,818 2,291 2,214
Nonmetro 17,986 17,151 5,259 5,073 3,015 3,020
Urbanized 8,164 7,788 2,480 2,321 1,430 1,488
Less Urbanized 8,189 8,124 2,389 2,460 1,392 1,395
Completely Rural 1,633 1,239 390 293 193 137
120404
Table 1.59B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 47.4 47.3 15.1 15.3 8.7 8.9
GEOGRAPHIC DIVISION            
Northeast 48.3 49.4 16.1 15.8 9.4 9.5
New England 54.4 54.0 19.5 18.0 11.9 11.5
Middle Atlantic 46.2 47.8 14.9 15.0 8.5 8.8
Midwest 48.4 47.4 13.9 14.2 7.9 8.2
East North Central 48.9 48.7 14.5 15.3 8.3 9.0
West North Central 47.3 44.6 12.6 11.8 7.0 6.4
South 44.6 44.5 13.8 13.6 7.8 7.8
South Atlantic 47.0 45.5 14.4 14.2 8.2 8.2
East South Central 43.0 44.6 12.1 12.6 6.9 7.1
West South Central 41.2 42.9 13.8 13.1 7.6 7.3
West 50.0 49.9 17.6 18.8 10.3 11.0
Mountain 50.1 51.1 16.7a 19.2 9.5 11.3
Pacific 50.0 49.3 18.0 18.6 10.6 10.9
COUNTY TYPE            
Large Metro 48.0 48.8 15.7 16.2 9.1 9.4
Small Metro 48.2 47.2 15.4 15.3 8.8 8.8
250K - 1 Mil. Pop. 49.1 48.3 15.6 15.6 8.9 9.0
< 250K Pop. 46.6 45.2 15.2 14.7 8.8 8.5
Nonmetro 43.6 42.4 12.7 12.5 7.3 7.5
Urbanized 45.2 45.6 13.7 13.6 7.9 8.7
Less Urbanized 43.0 41.3 12.6 12.5 7.3 7.1
Completely Rural 39.0 33.3 9.3 7.9 4.6 3.7
120404
Table 1.60A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 6,629a 6,278 4,838 4,745 2,484 2,468
GEOGRAPHIC DIVISION            
Northeast 1,063 1,073 825 840 447 479
New England 302 307 241 242 141 142
Middle Atlantic 761 767 584 598 306 337
Midwest 1,422a 1,320 1,020 986 557 506
East North Central 1,045b 933 771a 693 432a 364
West North Central 377 387 249 293 125 141
South 2,385a 2,200 1,686 1,657 796 792
South Atlantic 1,239 1,185 888 894 407 418
East South Central 390a 330 286 251 129 111
West South Central 756 686 512 512 260 264
West 1,758 1,684 1,308 1,261 684 690
Mountain 515 520 386 394 191 198
Pacific 1,243 1,163 922 867 493 492
COUNTY TYPE            
Large Metro 3,521 3,353 2,574 2,571 1,322 1,405
Small Metro 2,120 2,011 1,552 1,496 819 757
250K - 1 Mil. Pop. 1,426 1,393 1,061 1,030 573 544
< 250K Pop. 694 617 491 466 246 213
Nonmetro 987 914 711 677 343 306
Urbanized 447a 354 334 264 163a 116
Less Urbanized 456 490 322 364 154 167
Completely Rural 84 70 55 50 25 23
120404
Table 1.60B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 26.9a 25.8 19.7 19.5 10.1 10.1
GEOGRAPHIC DIVISION            
Northeast 24.7 25.3 19.2 19.8 10.4 11.3
New England 27.1 28.1 21.6 22.1 12.7 13.0
Middle Atlantic 23.8 24.4 18.3 19.0 9.6 10.7
Midwest 26.3 24.7 18.8 18.5 10.3 9.5
East North Central 27.6a 24.9 20.3 18.5 11.4a 9.7
West North Central 23.2 24.3 15.4 18.4 7.7 8.9
South 26.5a 24.6 18.7 18.5 8.8 8.8
South Atlantic 27.3 26.4 19.6 19.9 9.0 9.3
East South Central 26.8a 22.8 19.6 17.4 8.8 7.7
West South Central 25.1 22.7 17.0 16.9 8.6 8.7
West 29.9 28.9 22.2 21.7 11.6 11.9
Mountain 28.6 29.1 21.4 22.0 10.6 11.1
Pacific 30.5 28.9 22.6 21.5 12.1 12.2
COUNTY TYPE            
Large Metro 27.0 25.7 19.8 19.7 10.1 10.8
Small Metro 27.6 26.7 20.2 19.9 10.7 10.1
250K - 1 Mil. Pop. 27.9 27.7 20.7 20.5 11.2 10.8
< 250K Pop. 27.2 24.8 19.2 18.7 9.6 8.5
Nonmetro 25.3 24.1 18.2 17.9 8.8 8.1
Urbanized 26.1 23.2 19.5 17.3 9.5 7.6
Less Urbanized 25.3 25.3 17.9 18.8 8.6 8.6
Completely Rural 21.6 22.1 14.2 15.7 6.5 7.3
120404
Table 1.61A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 19,658 19,538 12,186 11,990 7,176 7,345
GEOGRAPHIC DIVISION            
Northeast 3,762 3,686 2,554 2,373 1,555 1,465
New England 1,102 1,112 769 778 477 509
Middle Atlantic 2,659 2,573 1,785a 1,596 1,078 956
Midwest 4,354 4,285 2,558 2,574 1,444 1,555
East North Central 3,093 2,974 1,850 1,828 1,063 1,115
West North Central 1,261 1,312 708 746 382 440
South 6,742 6,780 3,947 4,022 2,333 2,402
South Atlantic 3,497 3,497 2,112 2,166 1,215 1,325
East South Central 1,053 1,049 606 570 348 319
West South Central 2,193 2,234 1,229 1,285 770 758
West 4,799 4,787 3,128 3,020 1,845 1,923
Mountain 1,419 1,448 854 880 517 533
Pacific 3,380 3,339 2,274 2,140 1,328 1,390
COUNTY TYPE            
Large Metro 10,471 10,405 6,623 6,587 3,884 4,030
Small Metro 6,227 6,536 3,884 3,949 2,343 2,443
250K - 1 Mil. Pop. 3,966 4,233 2,443 2,541 1,441 1,554
< 250K Pop. 2,261 2,303 1,441 1,408 903 890
Nonmetro 2,960a 2,597 1,678 1,454 949 872
Urbanized 1,486 1,276 855 750 494 458
Less Urbanized 1,288 1,153 720 616 393 363
Completely Rural 186 168 103 88 62 51
120404
Table 1.61B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 58.5 57.3 36.3 35.2 21.4 21.6
GEOGRAPHIC DIVISION            
Northeast 61.5 61.0 41.7 39.3 25.4 24.2
New England 69.0 68.5 48.1 47.8 29.9 31.3
Middle Atlantic 58.8 58.2 39.5 36.1 23.8 21.6
Midwest 59.3 57.2 34.9 34.3 19.7 20.7
East North Central 60.9a 57.9 36.4 35.6 20.9 21.7
West North Central 55.8 55.7 31.3 31.7 16.9 18.7
South 56.1 54.6 32.8 32.4 19.4 19.3
South Atlantic 57.2 55.4 34.5 34.3 19.9 21.0
East South Central 55.4 52.8 31.9 28.7 18.3 16.1
West South Central 54.7 54.3 30.7 31.2 19.2 18.4
West 59.3 59.0 38.6 37.2 22.8 23.7
Mountain 58.6 58.0 35.3 35.3 21.4 21.4
Pacific 59.5 59.5 40.0 38.1 23.4 24.8
COUNTY TYPE            
Large Metro 58.7 57.3 37.1 36.3 21.8 22.2
Small Metro 59.4 58.8 37.0 35.5 22.3 22.0
250K - 1 Mil. Pop. 59.3 60.3 36.5 36.2 21.5 22.1
< 250K Pop. 59.4 56.2 37.9 34.4 23.7 21.7
Nonmetro 56.5 54.2 32.0 30.3 18.1 18.2
Urbanized 59.1 60.4 34.0 35.5 19.7 21.7
Less Urbanized 53.6a 49.5 30.0 26.4 16.3 15.6
Completely Rural 57.2 48.1 31.8 25.2 19.1 14.7
120404
Table 1.62A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 92,973 94,117 21,099 22,174 12,270 12,835
GEOGRAPHIC DIVISION            
Northeast 17,588 18,231 4,102 4,147 2,373 2,476
New England 5,220 5,195 1,360 1,191 834 762
Middle Atlantic 12,368 13,036 2,741 2,956 1,540 1,714
Midwest 20,942 20,642 4,089 4,312 2,352 2,473
East North Central 14,679 14,843 2,942 3,373 1,696 1,986
West North Central 6,263 5,799 1,147 939 655 487
South 31,888 32,413 7,098 6,959 4,080 4,034
South Atlantic 18,092 17,591 3,978 3,897 2,384 2,296
East South Central 5,002 5,347 923 1,086 565 646
West South Central 8,794 9,475 2,197 1,976 1,131 1,092
West 22,555 22,831 5,811a 6,756 3,465 3,852
Mountain 6,987 7,240 1,731a 2,194 989a 1,306
Pacific 15,568 15,591 4,080 4,562 2,476 2,546
COUNTY TYPE            
Large Metro 50,279 52,437 11,827 12,819 6,926 7,366
Small Metro 28,656 28,040 6,403 6,413 3,621 3,627
250K - 1 Mil. Pop. 19,450 19,221 4,372 4,469 2,478 2,515
< 250K Pop. 9,206 8,819 2,031 1,944 1,143 1,112
Nonmetro 14,038 13,641 2,870 2,942 1,723 1,842
Urbanized 6,231 6,158 1,291 1,307 773 914
Less Urbanized 6,445 6,481 1,347 1,480 845 866
Completely Rural 1,363 1,001 232 155 106 62
120404
Table 1.62B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 48.0 48.2 10.9 11.4 6.3 6.6
GEOGRAPHIC DIVISION            
Northeast 48.9 50.3 11.4 11.4 6.6 6.8
New England 55.1 54.5 14.4 12.5 8.8 8.0
Middle Atlantic 46.7 48.8 10.3 11.1 5.8 6.4
Midwest 49.4 48.6 9.6 10.1 5.5 5.8
East North Central 49.6 50.1 9.9 11.4 5.7 6.7
West North Central 48.9 45.1 8.9 7.3 5.1 3.8
South 44.9 45.3 10.0 9.7 5.7 5.6
South Atlantic 47.7 46.1 10.5 10.2 6.3 6.0
East South Central 43.0 45.9 7.9 9.3 4.9 5.5
West South Central 41.0 43.6 10.2 9.1 5.3 5.0
West 51.0 50.9 13.1 15.1 7.8 8.6
Mountain 51.4 52.7 12.7a 16.0 7.3a 9.5
Pacific 50.8 50.1 13.3 14.7 8.1 8.2
COUNTY TYPE            
Large Metro 48.8 50.2 11.5 12.3 6.7 7.0
Small Metro 48.9 47.7 10.9 10.9 6.2 6.2
250K - 1 Mil. Pop. 50.1 48.8 11.3 11.3 6.4 6.4
< 250K Pop. 46.6 45.5 10.3 10.0 5.8 5.7
Nonmetro 43.7 42.8 8.9 9.2 5.4 5.8
Urbanized 45.1 45.8 9.3 9.7 5.6 6.8
Less Urbanized 43.5 42.1 9.1 9.6 5.7 5.6
Completely Rural 39.2 32.8 6.7 5.1 3.0 2.0
120404
Table 1.63A (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 112,631 113,655 33,285 34,163 19,446 20,180
GEOGRAPHIC DIVISION            
Northeast 21,350 21,917 6,655 6,520 3,928 3,941
New England 6,323 6,308 2,129 1,968 1,311 1,271
Middle Atlantic 15,027 15,609 4,526 4,552 2,617 2,670
Midwest 25,296 24,927 6,647 6,886 3,796 4,028
East North Central 17,773 17,817 4,792 5,201 2,759 3,101
West North Central 7,524 7,111 1,855 1,685 1,037 927
South 38,631 39,193 11,045 10,980 6,413 6,436
South Atlantic 21,588 21,088 6,089 6,063 3,599 3,621
East South Central 6,055 6,396 1,529 1,656 913 965
West South Central 10,987 11,709 3,426 3,262 1,902 1,850
West 27,354 27,618 8,938 9,776 5,310 5,775
Mountain 8,406 8,688 2,585a 3,075 1,505a 1,839
Pacific 18,948 18,930 6,354 6,702 3,804 3,936
COUNTY TYPE            
Large Metro 60,749 62,842 18,450 19,406 10,810 11,395
Small Metro 34,883 34,576 10,287 10,362 5,964 6,070
250K - 1 Mil. Pop. 23,415 23,454 6,815 7,011 3,919 4,068
< 250K Pop. 11,467 11,122 3,472 3,352 2,045 2,002
Nonmetro 16,999 16,238 4,548 4,396 2,672 2,714
Urbanized 7,717 7,434 2,145 2,057 1,267 1,372
Less Urbanized 7,733 7,634 2,067 2,096 1,238 1,228
Completely Rural 1,549 1,169 335 243 168 114
120404
Table 1.63B (REVISED) – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 49.6 49.6 14.6 14.9 8.6 8.8
GEOGRAPHIC DIVISION            
Northeast 50.7 51.8 15.8 15.4 9.3 9.3
New England 57.1 56.5 19.2 17.6 11.8 11.4
Middle Atlantic 48.5 50.1 14.6 14.6 8.4 8.6
Midwest 50.8 49.8 13.4 13.8 7.6 8.1
East North Central 51.3 51.2 13.8 14.9 8.0 8.9
West North Central 49.9 46.7 12.3 11.1 6.9 6.1
South 46.5 46.7 13.3 13.1 7.7 7.7
South Atlantic 49.0 47.4 13.8 13.6 8.2 8.1
East South Central 44.7 46.9 11.3 12.1 6.7 7.1
West South Central 43.1 45.3 13.4 12.6 7.5 7.2
West 52.3 52.2 17.1 18.5 10.1 10.9
Mountain 52.5 53.5 16.1a 18.9 9.4 11.3
Pacific 52.2 51.6 17.5 18.3 10.5 10.7
COUNTY TYPE            
Large Metro 50.3 51.2 15.3 15.8 8.9 9.3
Small Metro 50.5 49.4 14.9 14.8 8.6 8.7
250K - 1 Mil. Pop. 51.4 50.5 15.0 15.1 8.6 8.8
< 250K Pop. 48.7 47.4 14.7 14.3 8.7 8.5
Nonmetro 45.5 44.3 12.2 12.0 7.2 7.4
Urbanized 47.3 47.8 13.1 13.2 7.8 8.8
Less Urbanized 44.9 43.1 12.0 11.8 7.2 6.9
Completely Rural 40.8 34.3 8.8 7.1 4.4 3.3
120404
Table 1.64A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 104,950 106,613 28,688 29,301 16,826 17,409
GEOGRAPHIC DIVISION            
Northeast 20,431 21,091 6,133 5,808 3,593 3,471
New England 6,216 6,140 2,007 1,831 1,242 1,153
Middle Atlantic 14,215 14,951 4,126 3,977 2,352 2,317
Midwest 23,836 23,357 5,842 5,989 3,428 3,563
East North Central 16,853 16,612 4,177 4,396 2,460 2,666
West North Central 6,982 6,746 1,665 1,593 968 897
South 35,155 36,311 9,023 9,044 5,192 5,256
South Atlantic 19,456 19,793 5,127 5,074 3,013 2,914
East South Central 5,597 5,746 1,279 1,313 692 745
West South Central 10,101 10,772 2,617 2,657 1,486 1,597
West 25,529 25,854 7,690 8,460 4,613 5,118
Mountain 7,801 8,039 2,119a 2,584 1,263 1,521
Pacific 17,728 17,815 5,571 5,876 3,350 3,597
COUNTY TYPE            
Large Metro 56,797 59,003 16,168 16,653 9,455 9,785
Small Metro 32,521 32,371 8,744 8,826 5,210 5,285
250K - 1 Mil. Pop. 21,819 22,125 5,743 5,929 3,450 3,540
< 250K Pop. 10,702 10,246 3,001 2,897 1,760 1,744
Nonmetro 15,632 15,239 3,776 3,822 2,162 2,339
Urbanized 7,182 6,899 1,766 1,756 1,017 1,177
Less Urbanized 7,025 7,258 1,729 1,840 1,006 1,062
Completely Rural 1,425 1,081 281 227 139 100
120404
Table 1.64B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 41.7 42.0 11.4 11.6 6.7 6.9
GEOGRAPHIC DIVISION            
Northeast 44.0 45.3 13.2 12.5 7.7 7.5
New England 51.0 50.1 16.5 14.9 10.2 9.4
Middle Atlantic 41.6 43.6 12.1 11.6 6.9 6.8
Midwest 43.2 42.2 10.6 10.8 6.2 6.4
East North Central 43.8 43.1 10.9 11.4 6.4 6.9
West North Central 41.8 40.1 10.0 9.5 5.8 5.3
South 38.2 39.1 9.8 9.7 5.6 5.7
South Atlantic 40.1 40.4 10.6 10.4 6.2 5.9
East South Central 37.3 38.1 8.5 8.7 4.6 4.9
West South Central 35.5 37.3 9.2 9.2 5.2 5.5
West 43.9 44.0 13.2 14.4 7.9 8.7
Mountain 43.8 44.6 11.9a 14.3 7.1 8.4
Pacific 43.9 43.7 13.8 14.4 8.3 8.8
COUNTY TYPE            
Large Metro 42.4 43.5 12.1 12.3 7.1 7.2
Small Metro 42.4 41.8 11.4 11.4 6.8 6.8
250K - 1 Mil. Pop. 43.1 43.0 11.3 11.5 6.8 6.9
< 250K Pop. 41.0 39.5 11.5 11.2 6.7 6.7
Nonmetro 37.9 37.7 9.2 9.4 5.2 5.8
Urbanized 39.8 40.4 9.8 10.3 5.6 6.9
Less Urbanized 36.9 36.9 9.1 9.4 5.3 5.4
Completely Rural 34.0 29.0 6.7 6.1 3.3 2.7
120404
Table 1.65A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 4,204 4,157 3,363 3,414 1,813 1,802
GEOGRAPHIC DIVISION            
Northeast 735 742 635 644 365 397
New England 226 227 198 192 114 119
Middle Atlantic 509 515 437 453 250 278
Midwest 928a 836 733 676 413 358
East North Central 692b 572 559b 470 325b 247
West North Central 236 263 174 206 89 111
South 1,382 1,428 1,071 1,151 535 549
South Atlantic 731 773 571 634 280 302
East South Central 188 197 139 157 63 68
West South Central 464 459 362 360 192 180
West 1,159 1,151 923 942 500 497
Mountain 349 364 278 291 156 135
Pacific 809 787 646 651 345 363
COUNTY TYPE            
Large Metro 2,249 2,208 1,829 1,859 973 1,020
Small Metro 1,343 1,364 1,066 1,083 619 560
250K - 1 Mil. Pop. 952 944 773 761 447 424
< 250K Pop. 390 420 292 322 173 135
Nonmetro 612 585 468 472 221 222
Urbanized 286a 218 217 178 108 84
Less Urbanized 278 327 217 262 98 123
Completely Rural 48 40 34 31 15 15
120404
Table 1.65B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 17.1 17.1 13.7 14.0 7.4 7.4
GEOGRAPHIC DIVISION            
Northeast 17.1 17.5 14.7 15.2 8.5 9.4
New England 20.3 20.7 17.8 17.5 10.3 10.9
Middle Atlantic 15.9 16.4 13.7 14.4 7.8 8.9
Midwest 17.1 15.7 13.5 12.7 7.6 6.7
East North Central 18.2b 15.3 14.7b 12.6 8.6b 6.6
West North Central 14.6 16.5 10.7 13.0 5.5 7.0
South 15.3 15.9 11.9 12.9 5.9 6.1
South Atlantic 16.1 17.2 12.6 14.1 6.2 6.7
East South Central 12.9 13.6 9.6 10.9 4.3 4.7
West South Central 15.4 15.2 12.0 11.9 6.4 6.0
West 19.7 19.8 15.7 16.2 8.5 8.5
Mountain 19.4 20.4 15.4 16.3 8.6 7.5
Pacific 19.8 19.5 15.8 16.1 8.5 9.0
COUNTY TYPE            
Large Metro 17.3 16.9 14.0 14.3 7.5 7.8
Small Metro 17.5 18.1 13.9 14.4 8.1 7.4
250K - 1 Mil. Pop. 18.6 18.7 15.1 15.1 8.7 8.4
< 250K Pop. 15.3 16.9 11.4 13.0 6.8 5.4
Nonmetro 15.7 15.5 12.0 12.5 5.7 5.9
Urbanized 16.7 14.3 12.6 11.7 6.3 5.5
Less Urbanized 15.5 16.8 12.0 13.5 5.4 6.3
Completely Rural 12.3 12.7 8.9 9.8 3.9 4.8
120404
Table 1.66A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 17,677 17,529 10,343 10,215 6,128 6,313
GEOGRAPHIC DIVISION            
Northeast 3,479 3,382 2,293a 2,068 1,375 1,285
New England 1,021 1,043 693 700 426 452
Middle Atlantic 2,459 2,339 1,601b 1,368 949 833
Midwest 3,893 3,869 2,165 2,218 1,241 1,344
East North Central 2,775 2,673 1,583 1,562 910 954
West North Central 1,118 1,196 582 655 331 390
South 5,999 5,937 3,248 3,312 1,934 2,034
South Atlantic 3,148 3,138 1,783 1,869 1,043 1,152
East South Central 903 879 472 453 275 255
West South Central 1,948 1,920 993 990 616 627
West 4,305 4,341 2,636 2,617 1,578 1,649
Mountain 1,223 1,286 697 729 413 439
Pacific 3,082 3,055 1,939 1,888 1,164 1,210
COUNTY TYPE            
Large Metro 9,461 9,387 5,729 5,695 3,419 3,493
Small Metro 5,584 5,851 3,240 3,314 1,942 2,091
250K - 1 Mil. Pop. 3,558 3,801 2,002 2,150 1,177 1,331
< 250K Pop. 2,026 2,050 1,238 1,165 765 760
Nonmetro 2,632 2,292 1,374 1,206 767 728
Urbanized 1,346 1,152 726 643 400 393
Less Urbanized 1,113 996 558 491 315 290
Completely Rural 174 143 90 72 52 45
120404
Table 1.66B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 52.6 51.4 30.8 30.0 18.2 18.5
GEOGRAPHIC DIVISION            
Northeast 56.8 56.0 37.5a 34.2 22.5 21.3
New England 63.9 64.2 43.4 43.1 26.6 27.8
Middle Atlantic 54.4 52.9 35.4a 31.0 21.0 18.8
Midwest 53.1 51.6 29.5 29.6 16.9 17.9
East North Central 54.7 52.0 31.2 30.4 17.9 18.6
West North Central 49.5 50.8 25.7 27.8 14.7 16.6
South 49.9 47.8 27.0 26.7 16.1 16.4
South Atlantic 51.5 49.7 29.2 29.6 17.1 18.2
East South Central 47.5 44.2 24.8 22.8 14.5 12.9
West South Central 48.6 46.7 24.8 24.1 15.4 15.2
West 53.2 53.5 32.5 32.3 19.5 20.3
Mountain 50.5 51.5 28.8 29.2 17.1 17.6
Pacific 54.3 54.4 34.1 33.6 20.5 21.6
COUNTY TYPE            
Large Metro 53.0 51.7 32.1 31.4 19.2 19.2
Small Metro 53.2 52.6 30.9 29.8 18.5 18.8
250K - 1 Mil. Pop. 53.2 54.1 29.9 30.6 17.6 19.0
< 250K Pop. 53.3 50.0 32.5 28.4 20.1 18.6
Nonmetro 50.2 47.8 26.2 25.2 14.6 15.2
Urbanized 53.5 54.6 28.9 30.4 15.9a 18.6
Less Urbanized 46.3 42.7 23.2 21.1 13.1 12.4
Completely Rural 53.6a 41.0 27.7 20.7 15.9 13.0
120404
Table 1.67A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 83,070 84,927 14,983 15,672 8,885 9,294
GEOGRAPHIC DIVISION            
Northeast 16,216 16,967 3,205 3,095 1,854 1,789
New England 4,969 4,871 1,116 939 702 582
Middle Atlantic 11,247 12,096 2,089 2,156 1,152 1,207
Midwest 19,015 18,653 2,944 3,095 1,773 1,860
East North Central 13,387 13,366 2,035 2,364 1,225 1,464
West North Central 5,628 5,286 909 732 548 396
South 27,774 28,945 4,703 4,580 2,723 2,673
South Atlantic 15,578 15,882 2,773 2,571 1,691 1,460
East South Central 4,506 4,671 668 703 354 422
West South Central 7,690 8,393 1,262 1,306 678 791
West 20,065 20,362 4,130 4,901 2,535 2,972
Mountain 6,229 6,389 1,144b 1,564 694a 948
Pacific 13,837 13,972 2,986 3,337 1,841 2,025
COUNTY TYPE            
Large Metro 45,087 47,408 8,610 9,099 5,063 5,272
Small Metro 25,595 25,156 4,439 4,429 2,649 2,634
250K - 1 Mil. Pop. 17,309 17,381 2,968 3,019 1,827 1,785
< 250K Pop. 8,286 7,776 1,471 1,410 822 849
Nonmetro 12,388 12,363 1,934 2,144 1,173 1,389
Urbanized 5,551 5,530 823 935 509 700
Less Urbanized 5,634 5,935 955 1,086 593 649
Completely Rural 1,203 898 157 123 72 39
120404
Table 1.67B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 42.9 43.5 7.7 8.0 4.6 4.8
GEOGRAPHIC DIVISION            
Northeast 45.1 46.8 8.9 8.5 5.2 4.9
New England 52.5 51.1 11.8 9.9 7.4 6.1
Middle Atlantic 42.5 45.3 7.9 8.1 4.3 4.5
Midwest 44.8 43.9 6.9 7.3 4.2 4.4
East North Central 45.2 45.1 6.9 8.0 4.1 4.9
West North Central 43.9 41.1 7.1 5.7 4.3 3.1
South 39.1 40.4 6.6 6.4 3.8 3.7
South Atlantic 41.1 41.6 7.3 6.7 4.5 3.8
East South Central 38.7 40.1 5.7 6.0 3.0 3.6
West South Central 35.8 38.6 5.9 6.0 3.2 3.6
West 45.4 45.4 9.3 10.9 5.7 6.6
Mountain 45.8 46.5 8.4a 11.4 5.1a 6.9
Pacific 45.2 44.9 9.7 10.7 6.0 6.5
COUNTY TYPE            
Large Metro 43.8 45.4 8.4 8.7 4.9 5.0
Small Metro 43.7 42.8 7.6 7.5 4.5 4.5
250K - 1 Mil. Pop. 44.6 44.1 7.6 7.7 4.7 4.5
< 250K Pop. 42.0 40.1 7.4 7.3 4.2 4.4
Nonmetro 38.6 38.8 6.0 6.7 3.7 4.4
Urbanized 40.2 41.1 6.0 7.0 3.7 5.2
Less Urbanized 38.0 38.6 6.4 7.1 4.0 4.2
Completely Rural 34.6 29.4 4.5 4.0 2.1 1.3
120404
Table 1.68A (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 100,747 102,456 25,325 25,887 15,013 15,607
GEOGRAPHIC DIVISION            
Northeast 19,695 20,349 5,498 5,164 3,229 3,074
New England 5,990 5,914 1,809 1,639 1,127 1,034
Middle Atlantic 13,705 14,436 3,689 3,524 2,101 2,039
Midwest 22,908 22,522 5,109 5,313 3,015 3,205
East North Central 16,162 16,039 3,618 3,926 2,135 2,419
West North Central 6,746 6,483 1,491 1,387 879 786
South 33,773 34,882 7,952 7,892 4,657 4,707
South Atlantic 18,726 19,020 4,556 4,440 2,734 2,613
East South Central 5,409 5,549 1,140 1,156 629 677
West South Central 9,638 10,313 2,256 2,297 1,294 1,417
West 24,371 24,703 6,766 7,518 4,113 4,621
Mountain 7,452 7,675 1,842b 2,293 1,107a 1,386
Pacific 16,919 17,028 4,925 5,225 3,005 3,235
COUNTY TYPE            
Large Metro 54,548 56,795 14,339 14,794 8,482 8,765
Small Metro 31,179 31,007 7,678 7,743 4,591 4,725
250K - 1 Mil. Pop. 20,867 21,181 4,970 5,168 3,004 3,116
< 250K Pop. 10,312 9,826 2,708 2,575 1,587 1,609
Nonmetro 15,020 14,655 3,308 3,350 1,941 2,117
Urbanized 6,896 6,682 1,549 1,577 909 1,093
Less Urbanized 6,746 6,932 1,512 1,578 908 939
Completely Rural 1,377 1,041 247 195 123 85
120404
Table 1.68B (REVISED) – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 44.3 44.7 11.1 11.3 6.6 6.8
GEOGRAPHIC DIVISION            
Northeast 46.8 48.1 13.1 12.2 7.7 7.3
New England 54.1 53.0 16.3 14.7 10.2 9.3
Middle Atlantic 44.2 46.3 11.9 11.3 6.8 6.5
Midwest 46.0 45.0 10.3 10.6 6.1 6.4
East North Central 46.6 46.1 10.4 11.3 6.2 7.0
West North Central 44.7 42.6 9.9 9.1 5.8 5.2
South 40.7 41.5 9.6 9.4 5.6 5.6
South Atlantic 42.5 42.7 10.3 10.0 6.2 5.9
East South Central 40.0 40.7 8.4 8.5 4.6 5.0
West South Central 37.8 39.9 8.9 8.9 5.1 5.5
West 46.6 46.6 12.9 14.2 7.9 8.7
Mountain 46.5 47.2 11.5a 14.1 6.9a 8.5
Pacific 46.6 46.4 13.6 14.2 8.3 8.8
COUNTY TYPE            
Large Metro 45.2 46.3 11.9 12.1 7.0 7.1
Small Metro 45.1 44.3 11.1 11.1 6.6 6.8
250K - 1 Mil. Pop. 45.8 45.6 10.9 11.1 6.6 6.7
< 250K Pop. 43.8 41.8 11.5 11.0 6.7 6.9
Nonmetro 40.2 40.0 8.9 9.1 5.2 5.8
Urbanized 42.2 43.0 9.5 10.1 5.6 7.0
Less Urbanized 39.2 39.1 8.8 8.9 5.3 5.3
Completely Rural 36.3 30.6 6.5 5.7 3.2 2.5
120404
Table 1.69A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 36,742 37,361 4,806 4,533 1,642 1,472
GEOGRAPHIC DIVISION            
Northeast 7,353 7,305 1,126 996 415 366
New England 2,472a 2,046 354 282 158 126
Middle Atlantic 4,881 5,259 772 714 257 240
Midwest 7,181 6,983 827 747 261 205
East North Central 4,955 4,870 604 573 204 169
West North Central 2,226 2,113 223 174 57 36
South 11,352 12,071 1,592 1,522 632 516
South Atlantic 5,868 6,672 918 897 379 301
East South Central 1,641 1,488 153 202 52 69
West South Central 3,843 3,911 521 423 200 146
West 10,856 11,002 1,260 1,268 334 385
Mountain 3,204 3,434 427 395 142 84
Pacific 7,652 7,569 833 873 193 301
COUNTY TYPE            
Large Metro 19,917 20,613 2,615 2,715 896 920
Small Metro 11,525 11,435 1,609 1,374 588 441
250K - 1 Mil. Pop. 7,685 7,633 1,131 935 473 330
< 250K Pop. 3,840 3,802 478 438 116 111
Nonmetro 5,300 5,313 582 444 157 111
Urbanized 2,438 2,476 280 207 42 64
Less Urbanized 2,456 2,519 271 224 112 46
Completely Rural 406 318 31 13 3 2
120404
Table 1.69B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.6 14.7 1.9 1.8 0.7 0.6
GEOGRAPHIC DIVISION            
Northeast 15.9 15.7 2.4 2.1 0.9 0.8
New England 20.3a 16.7 2.9 2.3 1.3 1.0
Middle Atlantic 14.3 15.3 2.3 2.1 0.8 0.7
Midwest 13.0 12.6 1.5 1.4 0.5 0.4
East North Central 12.9 12.6 1.6 1.5 0.5 0.4
West North Central 13.3 12.6 1.3 1.0 0.3 0.2
South 12.3 13.0 1.7 1.6 0.7 0.6
South Atlantic 12.1 13.6 1.9 1.8 0.8 0.6
East South Central 11.0 9.9 1.0 1.3 0.3 0.5
West South Central 13.5 13.5 1.8 1.5 0.7 0.5
West 18.6 18.7 2.2 2.2 0.6 0.7
Mountain 18.0 19.0 2.4 2.2 0.8 0.5
Pacific 18.9 18.6 2.1 2.1 0.5 0.7
COUNTY TYPE            
Large Metro 14.9 15.2 2.0 2.0 0.7 0.7
Small Metro 15.0 14.8 2.1 1.8 0.8 0.6
250K - 1 Mil. Pop. 15.2 14.8 2.2 1.8 0.9 0.6
< 250K Pop. 14.7 14.6 1.8 1.7 0.4 0.4
Nonmetro 12.8 13.1 1.4 1.1 0.4 0.3
Urbanized 13.5 14.5 1.6 1.2 0.2 0.4
Less Urbanized 12.9 12.8 1.4 1.1 0.6 0.2
Completely Rural 9.7 8.5 0.7 0.4 0.1 0.0
120404
Table 1.70A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 405 363 242 239 70 60
GEOGRAPHIC DIVISION            
Northeast 56 42 36 31 14 9
New England 15 15 10 8 3 2
Middle Atlantic 41 27 26 24 11 7
Midwest 72 62 47 42 12 9
East North Central 54a 35 37 22 9 5
West North Central 17 27 10 20 3 4
South 140 129 75 84 16 24
South Atlantic 58 43 27 27 5 11
East South Central 19 16 15 13 3 4
West South Central 62 70 33 45 7 8
West 138 130 83 82 29 19
Mountain 45a 27 25 15 6 3
Pacific 92 103 58 66 23 16
COUNTY TYPE            
Large Metro 200 189 126 133 33 30
Small Metro 153 128 87 72 27 16
250K - 1 Mil. Pop. 94 95 53 56 18 13
< 250K Pop. 58a 33 34 16 9 3
Nonmetro 52 46 29 34 10 15
Urbanized 26 15 18 14 4 7
Less Urbanized 23 28 11 19 5 8
Completely Rural 3 3 1 2 1 *
120404
Table 1.70B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 1.6 1.5 1.0 1.0 0.3 0.2
GEOGRAPHIC DIVISION            
Northeast 1.3 1.0 0.8 0.7 0.3 0.2
New England 1.3 1.4 0.9 0.7 0.3 0.1
Middle Atlantic 1.3 0.9 0.8 0.7 0.3 0.2
Midwest 1.3 1.2 0.9 0.8 0.2 0.2
East North Central 1.4a 0.9 1.0 0.6 0.2 0.1
West North Central 1.1 1.7 0.6 1.2 0.2 0.3
South 1.6 1.4 0.8 0.9 0.2 0.3
South Atlantic 1.3 1.0 0.6 0.6 0.1 0.2
East South Central 1.3 1.1 1.0 0.9 0.2 0.3
West South Central 2.1 2.3 1.1 1.5 0.2 0.3
West 2.3 2.2 1.4 1.4 0.5 0.3
Mountain 2.5a 1.5 1.4 0.9 0.3 0.1
Pacific 2.3 2.6 1.4 1.6 0.6 0.4
COUNTY TYPE            
Large Metro 1.5 1.4 1.0 1.0 0.3 0.2
Small Metro 2.0 1.7 1.1 1.0 0.3 0.2
250K - 1 Mil. Pop. 1.8 1.9 1.0 1.1 0.3 0.3
< 250K Pop. 2.3a 1.3 1.3 0.6 0.4 0.1
Nonmetro 1.3 1.2 0.8 0.9 0.3 0.4
Urbanized 1.5 1.0 1.0 0.9 0.3 0.5
Less Urbanized 1.3 1.4 0.6 1.0 0.3 0.4
Completely Rural 0.7 1.0 0.3 0.5 0.2 *
120404
Table 1.71A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 4,997b 4,568 1,790a 1,593 466 503
GEOGRAPHIC DIVISION            
Northeast 983b 807 462a 344 148 143
New England 309 259 149a 107 64 45
Middle Atlantic 673a 548 313 237 84 97
Midwest 992 942 330 295 88 78
East North Central 697 638 240 217 72 60
West North Central 294 304 90 78 15 18
South 1,671 1,552 552 467 117 121
South Atlantic 800 765 296 264 68 74
East South Central 213 181 53 45 9 13
West South Central 658 607 203 159 40 34
West 1,352 1,267 446 487 113 161
Mountain 487a 401 150 137 49 40
Pacific 864 866 296 350 64 121
COUNTY TYPE            
Large Metro 2,556 2,310 944 835 248 277
Small Metro 1,666 1,629 608 573 169 171
250K - 1 Mil. Pop. 1,105 1,037 395 363 122 116
< 250K Pop. 560 592 213 210 47 55
Nonmetro 775a 629 238 186 49 54
Urbanized 389 317 131 101 22 30
Less Urbanized 344a 265 95 82 24 23
Completely Rural 42 48 12b 2 3 1
120404
Table 1.71B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.9b 13.4 5.3a 4.7 1.4 1.5
GEOGRAPHIC DIVISION            
Northeast 16.1b 13.3 7.6a 5.7 2.4 2.4
New England 19.4 16.0 9.3a 6.6 4.0 2.8
Middle Atlantic 14.9a 12.4 6.9 5.4 1.9 2.2
Midwest 13.5 12.6 4.5 3.9 1.2 1.0
East North Central 13.7 12.4 4.7 4.2 1.4 1.2
West North Central 13.0 12.9 4.0 3.3 0.7 0.8
South 13.9 12.5 4.6 3.8 1.0 1.0
South Atlantic 13.1 12.1 4.8 4.2 1.1 1.2
East South Central 11.2 9.1 2.8 2.2 0.5 0.7
West South Central 16.4 14.7 5.1 3.9 1.0 0.8
West 16.7 15.6 5.5 6.0 1.4 2.0
Mountain 20.1b 16.0 6.2 5.5 2.0 1.6
Pacific 15.2 15.4 5.2 6.2 1.1 2.2
COUNTY TYPE            
Large Metro 14.3a 12.7 5.3 4.6 1.4 1.5
Small Metro 15.9 14.6 5.8 5.2 1.6 1.5
250K - 1 Mil. Pop. 16.5 14.8 5.9 5.2 1.8 1.7
< 250K Pop. 14.7 14.4 5.6 5.1 1.2 1.3
Nonmetro 14.8 13.1 4.5 3.9 0.9 1.1
Urbanized 15.5 15.0 5.2 4.8 0.9 1.4
Less Urbanized 14.3 11.4 4.0 3.5 1.0 1.0
Completely Rural 13.0 13.7 3.6b 0.7 0.8 0.3
120404
Table 1.72A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 31,339 32,430 2,773 2,700 1,106 909
GEOGRAPHIC DIVISION            
Northeast 6,314 6,456 627 621 253 214
New England 2,148 1,771 195 167 91 79
Middle Atlantic 4,166 4,684 432 454 162 135
Midwest 6,118 5,979 450 410 161 118
East North Central 4,204 4,198 327 334 123 104
West North Central 1,914 1,782 123 76 39 14
South 9,541 10,390 965 970 499 371
South Atlantic 5,009a 5,864 595 606 306 216
East South Central 1,409 1,292 85 144 39 52
West South Central 3,123 3,234 285 220 153 104
West 9,366 9,606 731 699 192 205
Mountain 2,671 3,006 252 242 87 41
Pacific 6,695 6,600 479 457 105 164
COUNTY TYPE            
Large Metro 17,161 18,114 1,546 1,747 615 612
Small Metro 9,706 9,678 913 729 393 254
250K - 1 Mil. Pop. 6,485 6,501 683 516 333 200
< 250K Pop. 3,221 3,177 231 213 59 54
Nonmetro 4,473 4,638 314 224 98 42
Urbanized 2,024 2,144 131 92 15 27
Less Urbanized 2,088 2,227 165 123 83 15
Completely Rural 361 268 17 9 * 1
120404
Table 1.72B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 16.2 16.6 1.4 1.4 0.6 0.5
GEOGRAPHIC DIVISION            
Northeast 17.6 17.8 1.7 1.7 0.7 0.6
New England 22.7 18.6 2.1 1.8 1.0 0.8
Middle Atlantic 15.7 17.5 1.6 1.7 0.6 0.5
Midwest 14.4 14.1 1.1 1.0 0.4 0.3
East North Central 14.2 14.2 1.1 1.1 0.4 0.4
West North Central 14.9 13.9 1.0 0.6 0.3 0.1
South 13.4 14.5 1.4 1.4 0.7 0.5
South Atlantic 13.2a 15.4 1.6 1.6 0.8 0.6
East South Central 12.1 11.1 0.7 1.2 0.3 0.4
West South Central 14.5 14.9 1.3 1.0 0.7 0.5
West 21.2 21.4 1.7 1.6 0.4 0.5
Mountain 19.6 21.9 1.9 1.8 0.6 0.3
Pacific 21.9 21.2 1.6 1.5 0.3 0.5
COUNTY TYPE            
Large Metro 16.7 17.3 1.5 1.7 0.6 0.6
Small Metro 16.6 16.5 1.6 1.2 0.7 0.4
250K - 1 Mil. Pop. 16.7 16.5 1.8 1.3 0.9 0.5
< 250K Pop. 16.3 16.4 1.2 1.1 0.3 0.3
Nonmetro 13.9 14.6 1.0 0.7 0.3 0.1
Urbanized 14.7 16.0 1.0 0.7 0.1 0.2
Less Urbanized 14.1 14.5 1.1 0.8 0.6 0.1
Completely Rural 10.4 8.8 0.5 0.3 * 0.0
120404
Table 1.73A (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 36,337 36,998 4,564 4,294 1,572 1,412
GEOGRAPHIC DIVISION            
Northeast 7,297 7,262 1,090 965 401 357
New England 2,458a 2,031 344 274 155 125
Middle Atlantic 4,839 5,232 746 691 246 232
Midwest 7,109 6,922 780 705 249 196
East North Central 4,901 4,836 567 551 195 164
West North Central 2,208 2,086 213 154 54 32
South 11,212 11,942 1,517 1,437 616 493
South Atlantic 5,809a 6,629 891 870 374 290
East South Central 1,622 1,473 138 189 49 65
West South Central 3,781 3,841 488 378 194 138
West 10,718 10,872 1,177 1,186 306 366
Mountain 3,159 3,407 402 379 136 81
Pacific 7,559 7,465 775 807 170 285
COUNTY TYPE            
Large Metro 19,717 20,424 2,489 2,582 863 889
Small Metro 11,372 11,307 1,522 1,302 562 425
250K - 1 Mil. Pop. 7,591 7,538 1,077 879 455 317
< 250K Pop. 3,781 3,769 444 423 107 109
Nonmetro 5,248 5,267 553 410 147 97
Urbanized 2,412 2,461 263 193 38 57
Less Urbanized 2,433 2,491 261 205 107 38
Completely Rural 403 315 29 11 3 2
120404
Table 1.73B (REVISED) – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 16.0 16.1 2.0 1.9 0.7 0.6
GEOGRAPHIC DIVISION            
Northeast 17.3 17.2 2.6 2.3 1.0 0.8
New England 22.2a 18.2 3.1 2.5 1.4 1.1
Middle Atlantic 15.6 16.8 2.4 2.2 0.8 0.7
Midwest 14.3 13.8 1.6 1.4 0.5 0.4
East North Central 14.1 13.9 1.6 1.6 0.6 0.5
West North Central 14.6 13.7 1.4 1.0 0.4 0.2
South 13.5 14.2 1.8 1.7 0.7 0.6
South Atlantic 13.2 14.9 2.0 2.0 0.8 0.7
East South Central 12.0 10.8 1.0 1.4 0.4 0.5
West South Central 14.8 14.9 1.9 1.5 0.8 0.5
West 20.5 20.5 2.2 2.2 0.6 0.7
Mountain 19.7 21.0 2.5 2.3 0.8 0.5
Pacific 20.8 20.3 2.1 2.2 0.5 0.8
COUNTY TYPE            
Large Metro 16.3 16.6 2.1 2.1 0.7 0.7
Small Metro 16.5 16.2 2.2 1.9 0.8 0.6
250K - 1 Mil. Pop. 16.7 16.2 2.4 1.9 1.0 0.7
< 250K Pop. 16.1 16.1 1.9 1.8 0.5 0.5
Nonmetro 14.1 14.4 1.5 1.1 0.4 0.3
Urbanized 14.8 15.8 1.6 1.2 0.2 0.4
Less Urbanized 14.1 14.1 1.5 1.2 0.6 0.2
Completely Rural 10.6 9.3 0.8 0.3 0.1 0.0
120404
Table 1.74A (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 8,390 9,208 1,008 885 497 378
GEOGRAPHIC DIVISION            
Northeast 1,248a 1,643 247 213 145 101
New England 372 521 79 83 62 57
Middle Atlantic 877 1,122 167 130 83 44
Midwest 1,792 1,757 183 185 74 79
East North Central 1,142 1,126 128 160 57 64
West North Central 650 631 55 25 17 15
South 2,865 3,329 408 342 206 165
South Atlantic 1,481 1,975 239 153 150 62
East South Central 486 542 57 79 6 39
West South Central 898 813 111 110 50 64
West 2,485 2,479 169 144 72 33
Mountain 771 844 80 51 40 9
Pacific 1,714 1,635 89 93 32 24
COUNTY TYPE            
Large Metro 4,098 4,619 495 469 226 202
Small Metro 2,750 3,145 342 349 221 155
250K - 1 Mil. Pop. 1,772 2,095 258 249 179 135
< 250K Pop. 978 1,050 84 99 42 20
Nonmetro 1,543 1,444 171b 67 50 21
Urbanized 729 671 63 39 12 14
Less Urbanized 680 709 103a 26 37 7
Completely Rural 133a 64 4 1 * *
120404
Table 1.74B (REVISED) – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 3.3 3.6 0.4 0.3 0.2 0.1
GEOGRAPHIC DIVISION            
Northeast 2.7a 3.5 0.5 0.5 0.3 0.2
New England 3.1 4.3 0.7 0.7 0.5 0.5
Middle Atlantic 2.6 3.3 0.5 0.4 0.2 0.1
Midwest 3.2 3.2 0.3 0.3 0.1 0.1
East North Central 3.0 2.9 0.3 0.4 0.1 0.2
West North Central 3.9 3.8 0.3 0.1 0.1 0.1
South 3.1 3.6 0.4 0.4 0.2 0.2
South Atlantic 3.0 4.0 0.5 0.3 0.3 0.1
East South Central 3.2 3.6 0.4 0.5 0.0 0.3
West South Central 3.2 2.8 0.4 0.4 0.2 0.2
West 4.3 4.2 0.3 0.2 0.1 0.1
Mountain 4.3 4.7 0.4 0.3 0.2 0.0
Pacific 4.2 4.0 0.2 0.2 0.1 0.1
COUNTY TYPE            
Large Metro 3.1 3.4 0.4 0.3 0.2 0.1
Small Metro 3.6 4.1 0.4 0.4 0.3 0.2
250K - 1 Mil. Pop. 3.5 4.1 0.5 0.5 0.4 0.3
< 250K Pop. 3.7 4.0 0.3 0.4 0.2 0.1
Nonmetro 3.7 3.6 0.4b 0.2 0.1 0.1
Urbanized 4.0 3.9 0.4 0.2 0.1 0.1
Less Urbanized 3.6 3.6 0.5a 0.1 0.2 0.0
Completely Rural 3.2 1.7 0.1 0.0 * *
120404
Table 1.75A (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 37,404 37,544 4,536 4,543 1,263 1,207
GEOGRAPHIC DIVISION            
Northeast 7,297 6,896 938 880 287a 163
New England 2,534a 2,113 338 256 115a 46
Middle Atlantic 4,763 4,784 601 624 172 116
Midwest 7,692 7,136 782 801 208 214
East North Central 5,233 4,981 549 556 148 149
West North Central 2,459 2,155 233 245 60 65
South 11,208 11,862 1,341 1,182 347 313
South Atlantic 5,930 6,599 630 611 155 197
East South Central 1,678 1,594 188 151 52 26
West South Central 3,600 3,669 523 420 140 90
West 11,206 11,649 1,475 1,680 421 517
Mountain 3,546 3,631 488 502 145 144
Pacific 7,661 8,019 986 1,178 276 373
COUNTY TYPE            
Large Metro 20,284 20,777 2,528 2,675 739 653
Small Metro 11,974 11,634 1,456 1,385 393 424
250K - 1 Mil. Pop. 8,018 7,763 904 916 227 264
< 250K Pop. 3,956 3,871 553 469 166 160
Nonmetro 5,145 5,133 552 483 131 130
Urbanized 2,579 2,459 303 267 46 89
Less Urbanized 2,163 2,345 216 196 79 40
Completely Rural 403 329 33 21 6 1
120404
Table 1.75B (REVISED) – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.9 14.8 1.8 1.8 0.5 0.5
GEOGRAPHIC DIVISION            
Northeast 15.7 14.8 2.0 1.9 0.6a 0.3
New England 20.8a 17.2 2.8 2.1 0.9a 0.4
Middle Atlantic 13.9 14.0 1.8 1.8 0.5 0.3
Midwest 13.9 12.9 1.4 1.4 0.4 0.4
East North Central 13.6 12.9 1.4 1.4 0.4 0.4
West North Central 14.7 12.8 1.4 1.5 0.4 0.4
South 12.2 12.8 1.5 1.3 0.4 0.3
South Atlantic 12.2 13.5 1.3 1.2 0.3 0.4
East South Central 11.2 10.6 1.3 1.0 0.3 0.2
West South Central 12.6 12.7 1.8 1.5 0.5 0.3
West 19.3 19.8 2.5 2.9 0.7 0.9
Mountain 19.9 20.1 2.7 2.8 0.8 0.8
Pacific 19.0 19.7 2.4 2.9 0.7 0.9
COUNTY TYPE            
Large Metro 15.2 15.3 1.9 2.0 0.6 0.5
Small Metro 15.6 15.0 1.9 1.8 0.5 0.5
250K - 1 Mil. Pop. 15.8 15.1 1.8 1.8 0.4 0.5
< 250K Pop. 15.2 14.9 2.1 1.8 0.6 0.6
Nonmetro 12.5 12.7 1.3 1.2 0.3 0.3
Urbanized 14.3 14.4 1.7 1.6 0.3 0.5
Less Urbanized 11.4 11.9 1.1 1.0 0.4 0.2
Completely Rural 9.6 8.8 0.8 0.6 0.1 0.0
120404
Table 1.76A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 22,552 21,778 2,109 2,048 562 690
GEOGRAPHIC DIVISION            
Northeast 4,464 4,088 374 451 84 147
New England 1,312 1,121 116 104 43 36
Middle Atlantic 3,153 2,968 258 347 40a 111
Midwest 4,749 4,425 367 397 100 117
East North Central 3,321 3,243 271 289 73 101
West North Central 1,428 1,182 96 108 26 17
South 6,947 7,025 620 667 116a 284
South Atlantic 3,923 3,934 331 379 73a 207
East South Central 1,076 1,010 127 111 17 30
West South Central 1,948 2,082 162 177 25 47
West 6,392 6,239 749a 533 263a 141
Mountain 1,911 1,931 119 144 36 56
Pacific 4,481 4,308 630a 389 227a 85
COUNTY TYPE            
Large Metro 12,557 12,091 1,221 1,199 350 439
Small Metro 6,595 6,882 595 589 145 194
250K - 1 Mil. Pop. 4,519 4,725 384 396 101 138
< 250K Pop. 2,076 2,157 211 192 44 56
Nonmetro 3,400a 2,805 293 260 67 58
Urbanized 1,637 1,349 128 107 32 24
Less Urbanized 1,414 1,255 142 123 28 27
Completely Rural 349a 201 23 30 7 7
120404
Table 1.76B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9.0 8.6 0.8 0.8 0.2 0.3
GEOGRAPHIC DIVISION            
Northeast 9.6 8.8 0.8 1.0 0.2 0.3
New England 10.8 9.1 0.9 0.9 0.4 0.3
Middle Atlantic 9.2 8.7 0.8 1.0 0.1a 0.3
Midwest 8.6 8.0 0.7 0.7 0.2 0.2
East North Central 8.6 8.4 0.7 0.8 0.2 0.3
West North Central 8.5 7.0 0.6 0.6 0.2 0.1
South 7.5 7.6 0.7 0.7 0.1a 0.3
South Atlantic 8.1 8.0 0.7 0.8 0.2 0.4
East South Central 7.2 6.7 0.8 0.7 0.1 0.2
West South Central 6.8 7.2 0.6 0.6 0.1 0.2
West 11.0 10.6 1.3a 0.9 0.5a 0.2
Mountain 10.7 10.7 0.7 0.8 0.2 0.3
Pacific 11.1 10.6 1.6a 1.0 0.6b 0.2
COUNTY TYPE            
Large Metro 9.4 8.9 0.9 0.9 0.3 0.3
Small Metro 8.6 8.9 0.8 0.8 0.2 0.3
250K - 1 Mil. Pop. 8.9 9.2 0.8 0.8 0.2 0.3
< 250K Pop. 8.0 8.3 0.8 0.7 0.2 0.2
Nonmetro 8.2a 6.9 0.7 0.6 0.2 0.1
Urbanized 9.1 7.9 0.7 0.6 0.2 0.1
Less Urbanized 7.4 6.4 0.7 0.6 0.1 0.1
Completely Rural 8.3 5.4 0.6 0.8 0.2 0.2
120404
Table 1.77A (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 2,283b 2,015 960 885 244 262
GEOGRAPHIC DIVISION            
Northeast 323 344 132 156 31 44
New England 75 100 35 46 12 18
Middle Atlantic 247 244 97 110 19 27
Midwest 486 447 211 191 62 58
East North Central 348 320 157 134 49 49
West North Central 138 127 54 56 13 9
South 827b 657 345 305 68 102
South Atlantic 432a 339 172 152 39 48
East South Central 150 139 75 76 14 23
West South Central 245b 179 98 77 14 32
West 646 567 272 234 83 58
Mountain 171 178 69 65 17 14
Pacific 475 389 203 169 66 44
COUNTY TYPE            
Large Metro 1,200 1,070 488 465 124 142
Small Metro 718 650 316 263 83 87
250K - 1 Mil. Pop. 455 464 208 179 58 56
< 250K Pop. 263a 186 108 84 25 31
Nonmetro 365a 295 155 157 37 33
Urbanized 159a 113 73 63 16 10
Less Urbanized 165 151 65 76 15 18
Completely Rural 42 30 17 19 7 5
120404
Table 1.77B (REVISED) – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9.3b 8.3 3.9 3.6 1.0 1.1
GEOGRAPHIC DIVISION            
Northeast 7.5 8.1 3.1 3.7 0.7 1.0
New England 6.8 9.1 3.1 4.2 1.0 1.6
Middle Atlantic 7.8 7.8 3.0 3.5 0.6 0.9
Midwest 9.0 8.4 3.9 3.6 1.2 1.1
East North Central 9.2 8.6 4.2 3.6 1.3 1.3
West North Central 8.5 8.0 3.3 3.5 0.8 0.6
South 9.2b 7.3 3.8 3.4 0.8a 1.1
South Atlantic 9.5a 7.5 3.8 3.4 0.9 1.1
East South Central 10.3 9.6 5.2 5.3 1.0 1.6
West South Central 8.1b 5.9 3.3 2.6 0.5 1.0
West 11.0 9.7 4.6 4.0 1.4 1.0
Mountain 9.5 10.0 3.8 3.6 0.9 0.8
Pacific 11.6 9.6 5.0 4.2 1.6 1.1
COUNTY TYPE            
Large Metro 9.2a 8.2 3.7 3.6 1.0 1.1
Small Metro 9.4 8.6 4.1 3.5 1.1 1.2
250K - 1 Mil. Pop. 8.9 9.2 4.1 3.5 1.1 1.1
< 250K Pop. 10.3b 7.5 4.2 3.4 1.0 1.2
Nonmetro 9.4a 7.8 4.0 4.2 1.0 0.9
Urbanized 9.3 7.4 4.3 4.1 0.9 0.6
Less Urbanized 9.2 7.8 3.6 3.9 0.8 1.0
Completely Rural 10.7 9.5 4.5 5.9 1.7 1.5
120404
Table 1.78A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 51,991 51,832 16,064 16,051 6,980 6,957
GEOGRAPHIC DIVISION            
Northeast 8,553 8,572 2,646 2,697 1,124 1,298
New England 2,357 2,346 774 758 303 411
Middle Atlantic 6,196 6,227 1,873 1,938 821 887
Midwest 10,639 10,678 3,289 3,268 1,368 1,383
East North Central 7,433 7,674 2,474 2,423 1,058 1,080
West North Central 3,206 3,004 815 845 311 303
South 18,725 18,348 5,960 5,602 2,675 2,524
South Atlantic 9,878 9,698 2,996 2,951 1,334 1,378
East South Central 2,991 3,241 948 874 495 404
West South Central 5,856 5,410 2,016 1,777 847 742
West 14,075 14,234 4,169 4,484 1,812 1,751
Mountain 4,362 4,523 1,389 1,460 635 603
Pacific 9,713 9,710 2,781 3,024 1,177 1,149
COUNTY TYPE            
Large Metro 27,343 28,305 8,297 8,711 3,590 3,671
Small Metro 16,609 16,190 5,235 5,100 2,187 2,214
250K - 1 Mil. Pop. 11,176 10,740 3,504 3,480 1,336 1,517
< 250K Pop. 5,433 5,450 1,731 1,620 851 697
Nonmetro 8,039 7,337 2,532 2,239 1,202 1,072
Urbanized 3,791 3,415 1,289 1,061 575 533
Less Urbanized 3,602 3,409 1,060 1,061 543 498
Completely Rural 646 513 183 117 83 41
120404
Table 1.78B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 20.6 20.4 6.4 6.3 2.8 2.7
GEOGRAPHIC DIVISION            
Northeast 18.4 18.4 5.7 5.8 2.4 2.8
New England 19.3 19.2 6.4 6.2 2.5 3.4
Middle Atlantic 18.1 18.2 5.5 5.7 2.4 2.6
Midwest 19.3 19.3 6.0 5.9 2.5 2.5
East North Central 19.3 19.9 6.4 6.3 2.7 2.8
West North Central 19.2 17.9 4.9 5.0 1.9 1.8
South 20.3 19.7 6.5 6.0 2.9 2.7
South Atlantic 20.3 19.8 6.2 6.0 2.7 2.8
East South Central 20.0 21.5 6.3 5.8 3.3 2.7
West South Central 20.6 18.7 7.1 6.2 3.0 2.6
West 24.2 24.2 7.2 7.6 3.1 3.0
Mountain 24.5 25.1 7.8 8.1 3.6 3.3
Pacific 24.0 23.8 6.9 7.4 2.9 2.8
COUNTY TYPE            
Large Metro 20.4 20.9 6.2 6.4 2.7 2.7
Small Metro 21.6 20.9 6.8 6.6 2.9 2.9
250K - 1 Mil. Pop. 22.1 20.9 6.9 6.8 2.6 2.9
< 250K Pop. 20.8 21.0 6.6 6.2 3.3 2.7
Nonmetro 19.5 18.1 6.1 5.5 2.9 2.6
Urbanized 21.0 20.0 7.1 6.2 3.2 3.1
Less Urbanized 18.9 17.3 5.6 5.4 2.9 2.5
Completely Rural 15.4 13.8 4.4 3.1 2.0 1.1
120404
Table 1.79A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 2,810a 2,591 1,895 1,812 774 721
GEOGRAPHIC DIVISION            
Northeast 383 336 266 247 106 94
New England 106 88 76 65 35 23
Middle Atlantic 277 248 190 182 71 71
Midwest 612 564 434 414 189 159
East North Central 453a 390 327 286 143 114
West North Central 158 174 107 128 46 45
South 1,085 975 717 651 296 266
South Atlantic 514 488 351 326 123 120
East South Central 220b 161 153b 103 76a 48
West South Central 351 326 212 222 96 98
West 731 715 479 500 183 202
Mountain 198a 252 140a 189 50 86
Pacific 533 463 339 311 133 116
COUNTY TYPE            
Large Metro 1,422 1,313 931 928 377 360
Small Metro 943 853 665 594 263 248
250K - 1 Mil. Pop. 571 577 393 405 153 166
< 250K Pop. 373a 276 271a 189 110 82
Nonmetro 445 425 299 291 134 113
Urbanized 217 179 157 133 65 53
Less Urbanized 197 219 124 143 59 51
Completely Rural 30 27 18 16 9 9
120404
Table 1.79B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 11.4a 10.6 7.7 7.4 3.1 3.0
GEOGRAPHIC DIVISION            
Northeast 8.9 7.9 6.2 5.8 2.5 2.2
New England 9.6 8.1 6.9 6.0 3.2 2.1
Middle Atlantic 8.7 7.9 6.0 5.8 2.2 2.3
Midwest 11.3 10.6 8.0 7.8 3.5 3.0
East North Central 12.0a 10.4 8.6 7.6 3.8 3.0
West North Central 9.8 11.0 6.6 8.0 2.8 2.8
South 12.0 10.9 8.0 7.3 3.3 3.0
South Atlantic 11.3 10.9 7.7 7.3 2.7 2.7
East South Central 15.1b 11.1 10.5b 7.1 5.2a 3.3
West South Central 11.6 10.8 7.1 7.4 3.2 3.2
West 12.4 12.3 8.1 8.6 3.1 3.5
Mountain 11.0a 14.1 7.7a 10.6 2.8 4.8
Pacific 13.1 11.5 8.3 7.7 3.3 2.9
COUNTY TYPE            
Large Metro 10.9 10.1 7.1 7.1 2.9 2.8
Small Metro 12.3 11.3 8.7 7.9 3.4 3.3
250K - 1 Mil. Pop. 11.2 11.5 7.7 8.0 3.0 3.3
< 250K Pop. 14.6b 11.1 10.6b 7.6 4.3 3.3
Nonmetro 11.4 11.2 7.7 7.7 3.4 3.0
Urbanized 12.7 11.7 9.1 8.7 3.8 3.5
Less Urbanized 11.0 11.3 6.9 7.4 3.3 2.6
Completely Rural 7.8 8.4 4.7 5.0 2.3 2.9
120404
Table 1.80A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9,896 9,832 5,061 4,876 2,133 1,997
GEOGRAPHIC DIVISION            
Northeast 1,746 1,666 992 893 434a 351
New England 523 517 306 263 147 116
Middle Atlantic 1,223 1,149 687 629 287 235
Midwest 2,198 2,107 1,090 1,107 450 472
East North Central 1,565 1,470 803 781 342 349
West North Central 634 637 287 326 107 123
South 3,512 3,664 1,806 1,763 759 712
South Atlantic 1,681 1,802 884 880 346 345
East South Central 630 605 310 277 136 126
West South Central 1,201 1,257 613 607 277 241
West 2,440 2,395 1,172 1,113 490 462
Mountain 785 749 382 347 162 154
Pacific 1,655 1,646 791 766 328 309
COUNTY TYPE            
Large Metro 4,992 5,049 2,559 2,520 1,014 983
Small Metro 3,327 3,411 1,707 1,703 767 736
250K - 1 Mil. Pop. 2,085 2,193 1,090 1,082 497 486
< 250K Pop. 1,242 1,218 617 621 270 250
Nonmetro 1,577 1,372 795 652 351 277
Urbanized 779 670 400 322 178 140
Less Urbanized 704 606 353 288 157 130
Completely Rural 95 96 42 43 17 8
120404
Table 1.80B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 29.5 28.9 15.1 14.3 6.4 5.9
GEOGRAPHIC DIVISION            
Northeast 28.5 27.6 16.2 14.8 7.1 5.8
New England 32.7 31.8 19.2 16.2 9.2 7.1
Middle Atlantic 27.0 26.0 15.2 14.2 6.3 5.3
Midwest 30.0 28.1 14.9 14.8 6.1 6.3
East North Central 30.8 28.6 15.8 15.2 6.7 6.8
West North Central 28.0 27.0 12.7 13.8 4.7 5.2
South 29.2 29.5 15.0 14.2 6.3 5.7
South Atlantic 27.5 28.5 14.5 13.9 5.7 5.5
East South Central 33.1 30.4 16.3 13.9 7.1 6.4
West South Central 30.0 30.6 15.3 14.7 6.9 5.9
West 30.1 29.5 14.5 13.7 6.1 5.7
Mountain 32.4 30.0 15.8 13.9 6.7 6.1
Pacific 29.1 29.3 13.9 13.6 5.8 5.5
COUNTY TYPE            
Large Metro 28.0 27.8 14.3 13.9 5.7 5.4
Small Metro 31.7 30.7 16.3 15.3 7.3 6.6
250K - 1 Mil. Pop. 31.2 31.2 16.3 15.4 7.4 6.9
< 250K Pop. 32.7 29.7 16.2 15.2 7.1 6.1
Nonmetro 30.1 28.6 15.2 13.6 6.7 5.8
Urbanized 31.0 31.7 15.9 15.2 7.1 6.6
Less Urbanized 29.3 26.0 14.7 12.4 6.5 5.6
Completely Rural 29.1 27.6 12.8 12.2 5.1a 2.2
120404
Table 1.81A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 39,285 39,409 9,108 9,362 4,072 4,239
GEOGRAPHIC DIVISION            
Northeast 6,424 6,570 1,387 1,557 584 853
New England 1,727 1,741 391 430 120b 272
Middle Atlantic 4,697 4,829 996 1,128 463 581
Midwest 7,829 8,007 1,765 1,746 730 753
East North Central 5,415 5,815 1,344 1,356 572 618
West North Central 2,414 2,192 421 391 158 135
South 14,128 13,708 3,437 3,188 1,621 1,546
South Atlantic 7,683 7,407 1,761 1,746 864 913
East South Central 2,141 2,475 485 494 283 230
West South Central 4,304 3,826 1,191 948 473 403
West 10,904 11,124 2,519 2,871 1,139 1,087
Mountain 3,379 3,522 867 924 423 363
Pacific 7,525 7,602 1,651 1,947 716 724
COUNTY TYPE            
Large Metro 20,929 21,943 4,807 5,263 2,198 2,328
Small Metro 12,339 11,926 2,863 2,804 1,157 1,230
250K - 1 Mil. Pop. 8,520 7,970 2,021 1,993 685 865
< 250K Pop. 3,818 3,956 843 810 472 365
Nonmetro 6,017 5,540 1,438 1,296 717 681
Urbanized 2,796 2,566 732 607 332 340
Less Urbanized 2,701 2,584 583 630 327 317
Completely Rural 521 390 123 59 58 24
120404
Table 1.81B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 20.3 20.2 4.7 4.8 2.1 2.2
GEOGRAPHIC DIVISION            
Northeast 17.9 18.1 3.9 4.3 1.6 2.4
New England 18.2 18.3 4.1 4.5 1.3b 2.9
Middle Atlantic 17.7 18.1 3.8 4.2 1.7 2.2
Midwest 18.5 18.8 4.2 4.1 1.7 1.8
East North Central 18.3 19.6 4.5 4.6 1.9 2.1
West North Central 18.8 17.0 3.3 3.0 1.2 1.0
South 19.9 19.1 4.8 4.5 2.3 2.2
South Atlantic 20.3 19.4 4.6 4.6 2.3 2.4
East South Central 18.4 21.2 4.2 4.2 2.4 2.0
West South Central 20.0 17.6 5.5 4.4 2.2 1.9
West 24.7 24.8 5.7 6.4 2.6 2.4
Mountain 24.9 25.6 6.4 6.7 3.1 2.6
Pacific 24.6 24.4 5.4 6.3 2.3 2.3
COUNTY TYPE            
Large Metro 20.3 21.0 4.7 5.0 2.1 2.2
Small Metro 21.1 20.3 4.9 4.8 2.0 2.1
250K - 1 Mil. Pop. 21.9 20.2 5.2 5.1 1.8 2.2
< 250K Pop. 19.3 20.4 4.3 4.2 2.4 1.9
Nonmetro 18.7 17.4 4.5 4.1 2.2 2.1
Urbanized 20.2 19.1 5.3 4.5 2.4 2.5
Less Urbanized 18.2 16.8 3.9 4.1 2.2 2.1
Completely Rural 15.0 12.7 3.5 1.9 1.7 0.8
120404
Table 1.82A (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 49,181 49,241 14,169 14,238 6,205 6,236
GEOGRAPHIC DIVISION            
Northeast 8,170 8,236 2,380 2,450 1,017 1,204
New England 2,250 2,258 697 693 267a 388
Middle Atlantic 5,920 5,978 1,683 1,757 750 816
Midwest 10,028 10,114 2,855 2,853 1,179 1,224
East North Central 6,979 7,284 2,147 2,137 914 967
West North Central 3,048 2,829 708 717 265 258
South 17,640 17,373 5,243 4,951 2,379 2,258
South Atlantic 9,364 9,209 2,645 2,625 1,210 1,258
East South Central 2,771 3,080 795 771 419 356
West South Central 5,505 5,084 1,804 1,555 750 644
West 13,344 13,519 3,691 3,984 1,629 1,550
Mountain 4,164 4,271 1,249 1,271 584 517
Pacific 9,180 9,248 2,442 2,713 1,044 1,033
COUNTY TYPE            
Large Metro 25,921 26,992 7,366 7,784 3,213 3,311
Small Metro 15,666 15,337 4,570 4,507 1,924 1,966
250K - 1 Mil. Pop. 10,605 10,164 3,111 3,075 1,183 1,351
< 250K Pop. 5,061 5,174 1,459 1,432 742 615
Nonmetro 7,594 6,912 2,233 1,948 1,068 958
Urbanized 3,574 3,236 1,132 928 510 480
Less Urbanized 3,405 3,190 935 918 484 447
Completely Rural 615 486 165 102 74 32
120404
Table 1.82B (REVISED) – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 21.6 21.5 6.2 6.2 2.7 2.7
GEOGRAPHIC DIVISION            
Northeast 19.4 19.5 5.7 5.8 2.4 2.8
New England 20.3 20.2 6.3 6.2 2.4a 3.5
Middle Atlantic 19.1 19.2 5.4 5.6 2.4 2.6
Midwest 20.2 20.2 5.7 5.7 2.4 2.4
East North Central 20.1 20.9 6.2 6.1 2.6 2.8
West North Central 20.2 18.6 4.7 4.7 1.8 1.7
South 21.2 20.7 6.3 5.9 2.9 2.7
South Atlantic 21.3 20.7 6.0 5.9 2.7 2.8
East South Central 20.5 22.6 5.9 5.7 3.1 2.6
West South Central 21.6 19.7 7.1 6.0 2.9 2.5
West 25.5 25.5 7.1 7.5 3.1 2.9
Mountain 26.0 26.3 7.8 7.8 3.6 3.2
Pacific 25.3 25.2 6.7 7.4 2.9 2.8
COUNTY TYPE            
Large Metro 21.5 22.0 6.1 6.3 2.7 2.7
Small Metro 22.7 21.9 6.6 6.4 2.8 2.8
250K - 1 Mil. Pop. 23.3 21.9 6.8 6.6 2.6 2.9
< 250K Pop. 21.5 22.0 6.2 6.1 3.1 2.6
Nonmetro 20.3 18.8 6.0 5.3 2.9 2.6
Urbanized 21.9 20.8 6.9 6.0 3.1 3.1
Less Urbanized 19.8 18.0 5.4 5.2 2.8 2.5
Completely Rural 16.2 14.3 4.3 3.0 2.0 0.9
120404
Table 1.83A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 35,197 34,908 12,450 12,242 5,282 5,093
GEOGRAPHIC DIVISION            
Northeast 5,851 5,656 2,088 1,987 893 904
New England 1,637 1,702 594 559 229 301
Middle Atlantic 4,215 3,954 1,494 1,428 663 604
Midwest 7,442 7,257 2,534 2,601 1,002 1,101
East North Central 5,370 5,391 1,918 1,912 779 860
West North Central 2,072 1,866 617 689 223 241
South 12,635 12,357 4,699a 4,092 2,069 1,759
South Atlantic 6,548 6,231 2,346 2,088 1,044 889
East South Central 2,096 2,334 706 676 351 318
West South Central 3,992 3,792 1,647a 1,327 674 552
West 9,268 9,639 3,129 3,562 1,319 1,328
Mountain 2,971 3,235 1,115 1,183 482 432
Pacific 6,297 6,404 2,014 2,380 837 896
COUNTY TYPE            
Large Metro 18,441 18,773 6,358 6,565 2,641 2,600
Small Metro 11,256 11,082 4,123 3,885 1,736 1,623
250K - 1 Mil. Pop. 7,533 7,263 2,737 2,609 1,051 1,135
< 250K Pop. 3,723 3,819 1,386 1,276 685a 488
Nonmetro 5,499 5,054 1,969 1,792 905 870
Urbanized 2,703 2,376 1,017 825 446 418
Less Urbanized 2,401 2,325 852 862 401 413
Completely Rural 396 353 101 106 59 39
120404
Table 1.83B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.0 13.8 4.9 4.8 2.1 2.0
GEOGRAPHIC DIVISION            
Northeast 12.6 12.2 4.5 4.3 1.9 1.9
New England 13.4 13.9 4.9 4.6 1.9 2.5
Middle Atlantic 12.3 11.5 4.4 4.2 1.9 1.8
Midwest 13.5 13.1 4.6 4.7 1.8 2.0
East North Central 14.0 14.0 5.0 5.0 2.0 2.2
West North Central 12.4 11.1 3.7 4.1 1.3 1.4
South 13.7 13.3 5.1a 4.4 2.2 1.9
South Atlantic 13.5 12.7 4.8 4.3 2.1 1.8
East South Central 14.0 15.5 4.7 4.5 2.3 2.1
West South Central 14.0 13.1 5.8a 4.6 2.4 1.9
West 15.9 16.4 5.4 6.1 2.3 2.3
Mountain 16.7 17.9 6.3 6.6 2.7 2.4
Pacific 15.6 15.7 5.0 5.8 2.1 2.2
COUNTY TYPE            
Large Metro 13.8 13.8 4.8 4.8 2.0 1.9
Small Metro 14.7 14.3 5.4 5.0 2.3 2.1
250K - 1 Mil. Pop. 14.9 14.1 5.4 5.1 2.1 2.2
< 250K Pop. 14.3 14.7 5.3 4.9 2.6a 1.9
Nonmetro 13.3 12.5 4.8 4.4 2.2 2.1
Urbanized 15.0 13.9 5.6 4.8 2.5 2.4
Less Urbanized 12.6 11.8 4.5 4.4 2.1 2.1
Completely Rural 9.5 9.5 2.4 2.8 1.4 1.0
120404
Table 1.84A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 2,393 2,245 1,628 1,522 658 607
GEOGRAPHIC DIVISION            
Northeast 309 290 220 216 83 86
New England 81 72 62 55 29 21
Middle Atlantic 229 217 158 161 55 65
Midwest 530 493 374 344 155 130
East North Central 392a 341 281 237 119 96
West North Central 138 153 93 107 36 34
South 930 840 615 540 250 219
South Atlantic 448 412 302 266 99 94
East South Central 186a 144 129a 89 68a 41
West South Central 296 284 183 184 83 84
West 623 621 419 422 169 172
Mountain 168a 218 112a 157 45 73
Pacific 455 403 307 265 124 99
COUNTY TYPE            
Large Metro 1,199 1,103 793 753 321 296
Small Metro 800 762 574 515 227 214
250K - 1 Mil. Pop. 489 515 350 359 135 150
< 250K Pop. 311 246 224a 156 92 64
Nonmetro 394 379 261 253 109 97
Urbanized 189 163 141 122 53 48
Less Urbanized 179 192 104 117 48 42
Completely Rural 27 25 16 14 8 8
120404
Table 1.84B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 9.7 9.2 6.6 6.3 2.7 2.5
GEOGRAPHIC DIVISION            
Northeast 7.2 6.8 5.1 5.1 1.9 2.0
New England 7.3 6.6 5.5 5.1 2.6 2.0
Middle Atlantic 7.2 6.9 5.0 5.1 1.7 2.1
Midwest 9.8 9.2 6.9 6.4 2.9 2.4
East North Central 10.3 9.1 7.4 6.3 3.1 2.6
West North Central 8.5 9.6 5.8 6.7 2.2 2.1
South 10.3 9.4 6.8 6.0 2.8 2.4
South Atlantic 9.9 9.2 6.7 5.9 2.2 2.1
East South Central 12.8a 10.0 8.9a 6.2 4.7a 2.9
West South Central 9.8 9.4 6.1 6.1 2.7 2.8
West 10.6 10.7 7.1 7.2 2.9 3.0
Mountain 9.3a 12.2 6.2a 8.8 2.5 4.1
Pacific 11.2 10.0 7.5 6.6 3.0 2.4
COUNTY TYPE            
Large Metro 9.2 8.5 6.1 5.8 2.5 2.3
Small Metro 10.4 10.1 7.5 6.9 3.0 2.8
250K - 1 Mil. Pop. 9.5 10.2 6.8 7.1 2.6 3.0
< 250K Pop. 12.2a 9.9 8.7b 6.3 3.6 2.6
Nonmetro 10.1 10.0 6.7 6.7 2.8 2.6
Urbanized 11.0 10.7 8.2 8.0 3.1 3.1
Less Urbanized 9.9 9.9 5.8 6.0 2.7 2.2
Completely Rural 6.9 7.9 4.2 4.5 2.1 2.5
120404
Table 1.85A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 8,221 8,143 4,027 3,779 1,610 1,510
GEOGRAPHIC DIVISION            
Northeast 1,468 1,369 800a 662 337a 255
New England 420 411 239 182 105 79
Middle Atlantic 1,048 958 561 481 232 176
Midwest 1,857 1,765 856 905 337 388
East North Central 1,325 1,244 634 641 256 285
West North Central 532 521 222 264 81 103
South 2,882 2,958 1,482a 1,316 581 506
South Atlantic 1,331 1,419 707 623 260 232
East South Central 542 512 251 226 112 87
West South Central 1,009 1,028 524 466 209 187
West 2,014 2,050 889 896 355 362
Mountain 662 636 322 278 132 113
Pacific 1,352 1,414 567 618 223 249
COUNTY TYPE            
Large Metro 4,094 4,140 2,023 1,913 747 730
Small Metro 2,791 2,840 1,355 1,351 587 570
250K - 1 Mil. Pop. 1,735 1,830 859 854 372 382
< 250K Pop. 1,057 1,010 496 496 214 188
Nonmetro 1,336 1,163 650a 515 277 210
Urbanized 667 578 330 254 136 110
Less Urbanized 587 501 285 221 125 93
Completely Rural 82 85 35 40 16 7
120404
Table 1.85B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 24.5 23.9 12.0a 11.1 4.8 4.4
GEOGRAPHIC DIVISION            
Northeast 24.0 22.6 13.1a 11.0 5.5a 4.2
New England 26.3 25.3 15.0a 11.2 6.6 4.8
Middle Atlantic 23.2 21.7 12.4 10.9 5.1 4.0
Midwest 25.3 23.5 11.7 12.1 4.6 5.2
East North Central 26.1 24.2 12.5 12.5 5.0 5.5
West North Central 23.5 22.1 9.8 11.2 3.6 4.4
South 24.0 23.8 12.3a 10.6 4.8 4.1
South Atlantic 21.8 22.5 11.6 9.9 4.3 3.7
East South Central 28.5 25.7 13.2 11.4 5.9 4.4
West South Central 25.2 25.0 13.1 11.3 5.2 4.5
West 24.9 25.3 11.0 11.0 4.4 4.5
Mountain 27.3 25.5 13.3 11.1 5.5 4.5
Pacific 23.8 25.2 10.0 11.0 3.9 4.4
COUNTY TYPE            
Large Metro 22.9 22.8 11.3 10.5 4.2 4.0
Small Metro 26.6 25.5 12.9 12.1 5.6 5.1
250K - 1 Mil. Pop. 25.9 26.0 12.8 12.2 5.6 5.4
< 250K Pop. 27.8 24.7 13.0 12.1 5.6 4.6
Nonmetro 25.5 24.3 12.4 10.8 5.3 4.4
Urbanized 26.5 27.4 13.1 12.0 5.4 5.2
Less Urbanized 24.4 21.5 11.9 9.5 5.2 4.0
Completely Rural 25.3 24.2 10.7 11.5 5.0a 2.0
120404
Table 1.86A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 24,583 24,521 6,795 6,941 3,014 2,975
GEOGRAPHIC DIVISION            
Northeast 4,074 3,997 1,067 1,108 473 563
New England 1,136 1,218 293 322 96a 201
Middle Atlantic 2,938 2,779 774 786 377 363
Midwest 5,055 4,998 1,304 1,352 509 583
East North Central 3,653 3,806 1,002 1,033 403 479
West North Central 1,402 1,192 302 319 106 104
South 8,823 8,558 2,602 2,236 1,238 1,034
South Atlantic 4,768 4,401 1,337 1,199 685 564
East South Central 1,368 1,678 325 361 171 190
West South Central 2,687 2,480 939 677 382 281
West 6,632 6,968 1,822 2,244 795 794
Mountain 2,141 2,381 681 747 304 246
Pacific 4,490 4,587 1,140 1,497 490 549
COUNTY TYPE            
Large Metro 13,148 13,529 3,542 3,898 1,573 1,574
Small Metro 7,665 7,480 2,194 2,019 922 838
250K - 1 Mil. Pop. 5,310 4,918 1,528 1,396 544 603
< 250K Pop. 2,355 2,562 666 623 378 236
Nonmetro 3,770 3,512 1,058 1,024 519 562
Urbanized 1,848 1,635 546 449 257 261
Less Urbanized 1,635 1,633 463 524 228 277
Completely Rural 286 243 50 51 34 24
120404
Table 1.86B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 12.7 12.6 3.5 3.6 1.6 1.5
GEOGRAPHIC DIVISION            
Northeast 11.3 11.0 3.0 3.1 1.3 1.6
New England 12.0 12.8 3.1 3.4 1.0a 2.1
Middle Atlantic 11.1 10.4 2.9 2.9 1.4 1.4
Midwest 11.9 11.8 3.1 3.2 1.2 1.4
East North Central 12.3 12.8 3.4 3.5 1.4 1.6
West North Central 10.9 9.3 2.4 2.5 0.8 0.8
South 12.4 12.0 3.7 3.1 1.7 1.4
South Atlantic 12.6 11.5 3.5 3.1 1.8 1.5
East South Central 11.8 14.4 2.8 3.1 1.5 1.6
West South Central 12.5 11.4 4.4a 3.1 1.8 1.3
West 15.0 15.5 4.1 5.0 1.8 1.8
Mountain 15.8 17.3 5.0 5.4 2.2 1.8
Pacific 14.7 14.8 3.7 4.8 1.6 1.8
COUNTY TYPE            
Large Metro 12.8 12.9 3.4 3.7 1.5 1.5
Small Metro 13.1 12.7 3.7 3.4 1.6 1.4
250K - 1 Mil. Pop. 13.7 12.5 3.9 3.5 1.4 1.5
< 250K Pop. 11.9 13.2 3.4 3.2 1.9 1.2
Nonmetro 11.7 11.0 3.3 3.2 1.6 1.8
Urbanized 13.4 12.2 4.0 3.3 1.9 1.9
Less Urbanized 11.0 10.6 3.1 3.4 1.5 1.8
Completely Rural 8.2 8.0 1.4 1.7 1.0 0.8
120404
Table 1.87A (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 32,804 32,664 10,822 10,720 4,624 4,485
GEOGRAPHIC DIVISION            
Northeast 5,542 5,366 1,868 1,771 809 818
New England 1,556 1,630 532 504 201 279
Middle Atlantic 3,986 3,736 1,336 1,267 609 539
Midwest 6,912 6,763 2,160 2,257 846 971
East North Central 4,978 5,051 1,637 1,674 660 764
West North Central 1,934 1,713 524 582 187 207
South 11,705 11,516 4,084a 3,552 1,819 1,540
South Atlantic 6,100 5,820 2,044 1,822 945 795
East South Central 1,910 2,190 577 587 282 277
West South Central 3,695 3,507 1,463a 1,143 592 468
West 8,645 9,018 2,710 3,140 1,149 1,156
Mountain 2,803 3,017 1,003 1,025 436 358
Pacific 5,842 6,001 1,707 2,115 713 798
COUNTY TYPE            
Large Metro 17,242 17,669 5,565 5,811 2,320 2,304
Small Metro 10,456 10,320 3,549 3,369 1,509 1,408
250K - 1 Mil. Pop. 7,044 6,748 2,387 2,250 916 985
< 250K Pop. 3,412 3,572 1,162 1,119 593a 424
Nonmetro 5,105 4,674 1,708 1,539 796 772
Urbanized 2,514 2,213 876 704 393 371
Less Urbanized 2,222 2,133 748 745 353 371
Completely Rural 369 328 84 91 50 31
120404
Table 1.87B (REVISED) – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2009 and 2010
Geographic Characteristic Lifetime
(2009)
Lifetime
(2010)
Past Year
(2009)
Past Year
(2010)
Past Month
(2009)
Past Month
(2010)
*Low precision; no estimate reported.
NOTE: This table was revised in May 2012 due to updates (for details, see the introduction to these 2010 detailed tables).
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
TOTAL 14.4 14.2 4.8 4.7 2.0 2.0
GEOGRAPHIC DIVISION            
Northeast 13.2 12.7 4.4 4.2 1.9 1.9
New England 14.1 14.6 4.8 4.5 1.8 2.5
Middle Atlantic 12.9 12.0 4.3 4.1 2.0 1.7
Midwest 13.9 13.5 4.3 4.5 1.7 1.9
East North Central 14.4 14.5 4.7 4.8 1.9 2.2
West North Central 12.8 11.3 3.5 3.8 1.2 1.4
South 14.1 13.7 4.9a 4.2 2.2 1.8
South Atlantic 13.9 13.1 4.6 4.1 2.1 1.8
East South Central 14.1 16.1 4.3 4.3 2.1 2.0
West South Central 14.5 13.6 5.7a 4.4 2.3 1.8
West 16.5 17.0 5.2 5.9 2.2 2.2
Mountain 17.5 18.6 6.3 6.3 2.7 2.2
Pacific 16.1 16.3 4.7 5.8 2.0 2.2
COUNTY TYPE            
Large Metro 14.3 14.4 4.6 4.7 1.9 1.9
Small Metro 15.1 14.8 5.1 4.8 2.2 2.0
250K - 1 Mil. Pop. 15.5 14.5 5.2 4.8 2.0 2.1
< 250K Pop. 14.5 15.2 4.9 4.8 2.5 1.8
Nonmetro 13.7 12.7 4.6 4.2 2.1 2.1
Urbanized 15.4 14.2 5.4 4.5 2.4 2.4
Less Urbanized 12.9 12.0 4.3 4.2 2.0 2.1
Completely Rural 9.7 9.6 2.2 2.7 1.3 0.9
110517
Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2009 and 2010
Drug or Method of Administration Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
HALLUCINOGENS 37,256 37,476 1,012 999 6,365 6,261 29,879 30,216
PCP (Angel Dust, Phencyclidine) 6,239 6,258 99 76 468 437 5,672 5,744
LSD (Acid) 23,635 23,320 249 231 2,294 2,176 21,092 20,913
Peyote 5,196 5,776 63 42 345 331 4,788 5,403
Mescaline 8,252 8,663 26 40 356 380 7,870 8,242
Psilocybin (Mushrooms) 21,170 21,126 406 366 3,810 3,776 16,954 16,984
Ecstasy (MDMA) 14,234b 15,901 572 619 4,168 4,216 9,494b 11,066
INHALANTS 22,448 21,660 2,267b 2,005 3,581 3,363 16,599 16,292
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 7,407 7,176 370 336 565 600 6,472 6,240
Correction Fluid, Degreaser, or Cleaning Fluid 1,818 1,956 460 411 308 327 1,050 1,218
Gasoline or Lighter Fluid 3,743 3,385 773b 633 521 496 2,449 2,256
Glue, Shoe Polish, or Toluene 3,558 4,019 784 770 463 481 2,311 2,768
Halothane, Ether, or Other Anesthetics 1,158 1,042 74 79 215 195 868 767
Lacquer Thinner or Other Paint Solvents 1,710 1,826 353 287 309 316 1,048 1,224
Lighter Gases (Butane, Propane) 926 831 227a 158 162 161 538 512
Nitrous Oxide or Whippits 12,401 12,222 258 259 2,260 2,070 9,883 9,894
Spray Paints 1,998 2,098 713b 554 381 438 904 1,106
Other Aerosol Sprays 2,381 2,147 501 423 629 579 1,252 1,145
NEEDLE USE1,2,3 3,782 3,635 59 46 427 372 3,296 3,217
Heroin Needle Use1,2 1,499 1,757 27 24 216 227 1,256 1,506
Cocaine Needle Use1,2 2,119 2,265 16 * 152 154 1,951 2,111
Stimulant Needle Use1,2,3 1,920 1,812 26 17 184 129 1,710 1,665
Methamphetamine Needle Use1,2,3 1,589 1,557 18 11 147 104 1,424 1,441
HEROIN 3,683 4,126 56 46 573 607 3,054 3,473
Smoke Heroin2 1,358 1,465 30 22 226 244 1,102 1,199
Sniff or Snort Heroin2 2,516a 3,064 27 17 442 425 2,047a 2,622
110517
Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2009 and 2010
Drug or Method of Administration Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
HALLUCINOGENS 14.8 14.8 4.1 4.1 19.0 18.4 15.4 15.5
PCP (Angel Dust, Phencyclidine) 2.5 2.5 0.4 0.3 1.4 1.3 2.9 2.9
LSD (Acid) 9.4 9.2 1.0 0.9 6.8 6.4 10.9 10.7
Peyote 2.1 2.3 0.3 0.2 1.0 1.0 2.5 2.8
Mescaline 3.3 3.4 0.1 0.2 1.1 1.1 4.1 4.2
Psilocybin (Mushrooms) 8.4 8.3 1.7 1.5 11.3 11.1 8.8 8.7
Ecstasy (MDMA) 5.7b 6.3 2.3 2.5 12.4 12.4 4.9b 5.7
INHALANTS 8.9 8.5 9.2b 8.2 10.7a 9.9 8.6 8.3
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 2.9 2.8 1.5 1.4 1.7 1.8 3.3 3.2
Correction Fluid, Degreaser, or Cleaning Fluid 0.7 0.8 1.9 1.7 0.9 1.0 0.5 0.6
Gasoline or Lighter Fluid 1.5 1.3 3.1a 2.6 1.6 1.5 1.3 1.2
Glue, Shoe Polish, or Toluene 1.4 1.6 3.2 3.2 1.4 1.4 1.2 1.4
Halothane, Ether, or Other Anesthetics 0.5 0.4 0.3 0.3 0.6 0.6 0.4 0.4
Lacquer Thinner or Other Paint Solvents 0.7 0.7 1.4 1.2 0.9 0.9 0.5 0.6
Lighter Gases (Butane, Propane) 0.4 0.3 0.9a 0.6 0.5 0.5 0.3 0.3
Nitrous Oxide or Whippits 4.9 4.8 1.0 1.1 6.7a 6.1 5.1 5.1
Spray Paints 0.8 0.8 2.9b 2.3 1.1 1.3 0.5 0.6
Other Aerosol Sprays 0.9 0.8 2.0 1.7 1.9 1.7 0.6 0.6
NEEDLE USE1,2,3 1.5 1.4 0.2 0.2 1.3 1.1 1.7 1.6
Heroin Needle Use1,2 0.6 0.7 0.1 0.1 0.6 0.7 0.6 0.8
Cocaine Needle Use1,2 0.8 0.9 0.1 * 0.5 0.5 1.0 1.1
Stimulant Needle Use1,2,3 0.8 0.7 0.1 0.1 0.5 0.4 0.9 0.9
Methamphetamine Needle Use1,2,3 0.6 0.6 0.1 0.0 0.4 0.3 0.7 0.7
HEROIN 1.5 1.6 0.2 0.2 1.7 1.8 1.6 1.8
Smoke Heroin2 0.5 0.6 0.1 0.1 0.7 0.7 0.6 0.6
Sniff or Snort Heroin2 1.0 1.2 0.1 0.1 1.3 1.2 1.1a 1.3
110405
Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2009 and 2010
Pain Reliever Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Darvocet®, Darvon®, or Tylenol® with Codeine 18,889 17,839 1,051 964 3,475a 3,216 14,363 13,659
Percocet®, Percodan®, or Tylox® 13,570 13,753 469 418 3,219 3,171 9,883 10,164
Vicodin®, Lortab®, or Lorcet® 22,065 22,479 1,104 988 6,088 5,956 14,873 15,535
Codeine 7,120 6,790 349 378 1,953 1,854 4,818 4,558
Demerol® 2,219 2,394 61 54 445 434 1,712 1,907
Dilaudid® 1,092 1,095 20 14 193b 284 879 797
Fioricet® 430 373 16 15 82 62 332 296
Fiorinal® 342 257 8 11 25 16 309 230
Hydrocodone 9,626 10,208 429 490 2,950 3,109 6,248 6,609
Methadone 2,026 2,189 115 139 688a 821 1,223 1,228
Morphine 2,748 3,018 182 159 985 1,009 1,580 1,850
OxyContin® 5,829 6,121 378 366 2,084 2,129 3,368 3,626
Phenaphen® with Codeine 602 598 44 50 159 160 399 388
Propoxyphene 318a 190 22 35 100 63 196a 92
SK-65® 67 64 6 15 18 29 43 19
Stadol® 81 94 2 3 26 18 53 73
Talacen® 77 38 9 7 7 17 60 14
Talwin® 234 278 11 10 10 12 213 255
Talwin® NX 78 63 5 6 15 22 58 35
Tramadol 1,443 1,711 90 86 567 605 786 1,020
Ultram® 1,359 1,229 54 42 362a 282 943 905
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 20,985a 19,663 1,201 1,141 4,135 3,880 15,649 14,643
Oxycodone Products3 15,281 15,553 691 639 3,893 3,933 10,697 10,981
Hydrocodone Products4 23,543 24,093 1,238 1,148 6,512 6,479 15,794 16,467
Tramadol Products5 2,181 2,269 129 113 762 692 1,289 1,464
110405
Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2009 and 2010
Pain Reliever Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Darvocet®, Darvon®, or Tylenol® with Codeine 7.5 7.0 4.3 4.0 10.3a 9.4 7.4 7.0
Percocet®, Percodan®, or Tylox® 5.4 5.4 1.9 1.7 9.6 9.3 5.1 5.2
Vicodin®, Lortab®, or Lorcet® 8.8 8.9 4.5 4.1 18.1 17.5 7.7 8.0
Codeine 2.8 2.7 1.4 1.6 5.8 5.4 2.5 2.3
Demerol® 0.9 0.9 0.2 0.2 1.3 1.3 0.9 1.0
Dilaudid® 0.4 0.4 0.1 0.1 0.6a 0.8 0.5 0.4
Fioricet® 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.2
Fiorinal® 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1
Hydrocodone 3.8 4.0 1.7 2.0 8.8 9.1 3.2 3.4
Methadone 0.8 0.9 0.5 0.6 2.0 2.4 0.6 0.6
Morphine 1.1 1.2 0.7 0.7 2.9 3.0 0.8 0.9
OxyContin® 2.3 2.4 1.5 1.5 6.2 6.2 1.7 1.9
Phenaphen® with Codeine 0.2 0.2 0.2 0.2 0.5 0.5 0.2 0.2
Propoxyphene 0.1a 0.1 0.1 0.1 0.3 0.2 0.1a 0.0
SK-65® 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0
Stadol® 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Talacen® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Talwin® 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Talwin® NX 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Tramadol 0.6 0.7 0.4 0.4 1.7 1.8 0.4 0.5
Ultram® 0.5 0.5 0.2 0.2 1.1a 0.8 0.5 0.5
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 8.3a 7.8 4.9 4.7 12.3a 11.4 8.1 7.5
Oxycodone Products3 6.1 6.1 2.8 2.6 11.6 11.5 5.5 5.6
Hydrocodone Products4 9.3 9.5 5.0 4.7 19.4 19.0 8.2 8.4
Tramadol Products5 0.9 0.9 0.5 0.5 2.3 2.0 0.7 0.8
110405
Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2009 and 2010
Tranquilizer Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Klonopin® or Clonazepam 4,725 4,729 162 193 1,400 1,393 3,163 3,144
Xanax®, Alprazolam, Ativan®, or Lorazepam 12,846 13,645 487 541 3,346 3,582 9,014 9,522
Valium® or Diazepam 13,338 13,468 210 215 1,992 1,986 11,136 11,267
Atarax® 307 182 20 23 39 46 248a 114
BuSpar® 489 532 26 13 148 154 314 365
Equanil® 73 58 5 8 12 8 56 42
Flexeril® 2,399 2,569 46 56 539 500 1,814 2,013
Librium® 874 795 14 16 47 59 812 720
Limbitrol® 87 99 14 8 34 15 40 76
Meprobamate 106 64 12 9 21 26 73 29
Miltown® 76 59 4 10 5 7 66 42
Rohypnol® 295 336 22 11 66 60 207 265
Serax® 74 64 11 9 21 25 42 30
Soma® 2,949 3,240 104 117 928 916 1,917 2,207
Tranxene® 157a 66 16 * 20 19 121 47
Vistaril® 200 277 14 18 46 56 140 203
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 20,449 20,708 625 642 4,086 4,261 15,739 15,805
Meprobamate Products3 228 158 19 22 27 33 182 104
Muscle Relaxants4 4,453 4,761 140 162 1,205 1,155 3,108 3,444
110405
Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2009 and 2010
Tranquilizer Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Klonopin® or Clonazepam 1.9 1.9 0.7 0.8 4.2 4.1 1.6 1.6
Xanax®, Alprazolam, Ativan®, or Lorazepam 5.1 5.4 2.0 2.2 10.0 10.5 4.7 4.9
Valium® or Diazepam 5.3 5.3 0.9 0.9 5.9 5.8 5.8 5.8
Atarax® 0.1 0.1 0.1 0.1 0.1 0.1 0.1a 0.1
BuSpar® 0.2 0.2 0.1 0.1 0.4 0.5 0.2 0.2
Equanil® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Flexeril® 1.0 1.0 0.2 0.2 1.6 1.5 0.9 1.0
Librium® 0.3 0.3 0.1 0.1 0.1 0.2 0.4 0.4
Limbitrol® 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0
Meprobamate 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Miltown® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rohypnol® 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1
Serax® 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Soma® 1.2 1.3 0.4 0.5 2.8 2.7 1.0 1.1
Tranxene® 0.1a 0.0 0.1 * 0.1 0.1 0.1 0.0
Vistaril® 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 8.1 8.2 2.5 2.6 12.2 12.5 8.1 8.1
Meprobamate Products3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Muscle Relaxants4 1.8 1.9 0.6 0.7 3.6 3.4 1.6 1.8
110517
Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2009 and 2010
Stimulant Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Methamphetamine, Desoxyn®, or Methedrine1 12,837 13,012 185 157 1,511 1,353 11,141 11,503
Prescription Diet Pills2 7,861 7,342 158 127 693 694 7,010 6,522
Ritalin® or Methylphenidate 5,363 5,422 269 250 1,754 1,818 3,340 3,354
Cylert® 181 105 13 9 33 41 135 55
Dexedrine® 2,357 1,829 21 14 164 145 2,172 1,670
Dextroamphetamine 668 791 28 27 183 190 457 573
Didrex® 203 95 9 7 22 18 171 69
Eskatrol® 150 97 9 6 13 26 128 64
Ionamin® 362 236 15 5 8 6 339 225
Mazanor® 21 26 5 3 6 13 10 10
Obedrin-LA® * * 6 * 4 3 * *
Plegine® 20 * 6 4 8 8 * *
Preludin® 392 431 9 5 16 26 367 400
Sanorex® 67 50 9 8 19a 5 38 37
Tenuate® 118 63 6 8 11 4 100 50
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 9,794 9,525 239 201 1,424 1,535 8,131 7,789
Mazindol Products5 84 73 13 9 22 17 48 47
Methylphenidate or Dexmethylphenidate Products6 5,376 5,445 270 258 1,766 1,830 3,340 3,357
110517
Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2009 and 2010
Stimulant Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Methamphetamine, Desoxyn®, or Methedrine1 5.1 5.1 0.8 0.6 4.5a 4.0 5.8 5.9
Prescription Diet Pills2 3.1 2.9 0.6 0.5 2.1 2.0 3.6 3.3
Ritalin® or Methylphenidate 2.1 2.1 1.1 1.0 5.2 5.3 1.7 1.7
Cylert® 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0
Dexedrine® 0.9 0.7 0.1 0.1 0.5 0.4 1.1 0.9
Dextroamphetamine 0.3 0.3 0.1 0.1 0.5 0.6 0.2 0.3
Didrex® 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0
Eskatrol® 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0
Ionamin® 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1
Mazanor® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Obedrin-LA® * * 0.0 * 0.0 0.0 * *
Plegine® 0.0 * 0.0 0.0 0.0 0.0 * *
Preludin® 0.2 0.2 0.0 0.0 0.0 0.1 0.2 0.2
Sanorex® 0.0 0.0 0.0 0.0 0.1a 0.0 0.0 0.0
Tenuate® 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 3.9 3.8 1.0 0.8 4.2 4.5 4.2 4.0
Mazindol Products5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0
Methylphenidate or Dexmethylphenidate Products6 2.1 2.1 1.1 1.1 5.3 5.4 1.7 1.7
110405
Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2009 and 2010
Sedative Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Methaqualone, Sopor®, or Quaalude® 5,728 5,059 25 41 154 118 5,549 4,899
Barbiturates1 2,449 2,023 27 20 85 76 2,337 1,927
Restoril® or Temazepam 1,187 1,033 46 43 147 135 994 854
Amytal® 210 231 9 5 24 30 177 196
Butisol® 84 104 6 17 7 15 71 71
Chloral Hydrate 153 132 2 6 19 10 132 116
Dalmane® 281 219 16 8 18 19 247 193
Halcion® 526 571 15 23 25 39 486 510
Phenobarbital 982 856 16 24 62 48 904 785
Placidyl® 493 406 2 5 5 8 486 394
Tuinal® 729 516 10 2 6 9 713 505
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 1,667 1,558 70 68 164 158 1,433 1,332
Any Barbiturates4 3,036 2,642 54 55 149 120 2,833 2,466
110405
Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2009 and 2010
Sedative Total
(2009)
Total
(2010)
Aged 12-17
(2009)
Aged 12-17
(2010)
Aged 18-25
(2009)
Aged 18-25
(2010)
Aged 26+
(2009)
Aged 26+
(2010)
*Low precision; no estimate reported.
a Difference between estimate and 2010 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2010 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality (formerly the Office of Applied Studies), National Survey on Drug Use and Health, 2009 and 2010.
Methaqualone, Sopor®, or Quaalude® 2.3 2.0 0.1 0.2 0.5 0.3 2.9 2.5
Barbiturates1 1.0 0.8 0.1 0.1 0.3 0.2 1.2 1.0
Restoril® or Temazepam 0.5 0.4 0.2 0.2 0.4 0.4 0.5 0.4
Amytal® 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1
Butisol® 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0
Chloral Hydrate 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1
Dalmane® 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1
Halcion® 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.3
Phenobarbital 0.4 0.3 0.1 0.1 0.2 0.1 0.5 0.4
Placidyl® 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2
Tuinal® 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.3
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.7 0.6 0.3 0.3 0.5 0.5 0.7 0.7
Any Barbiturates4 1.2 1.0 0.2 0.2 0.4 0.4 1.5 1.3

Go to Top of PageGo to the Table of Contents

This is the page footer.

This page was last updated on .